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Inflammation is a protective response exerted by the organism to eliminate an injurious stimulus. 
Endothelial cells play a fundamental role in different physiological processes since, changing their 
phenotype, modulate the complement and coagulation cascades, inflammation and innate and 
adaptive immunity. Medicinal plants have been the main remedy to treat different ailments and 
their study has permitted the development of many drugs.  
The aim of the present research was to study the phytochemical composition and the anti-
inflammatory activity of four medicinal plants (Cucumis sativus L, Boswellia serrata Roxb. 
Colebr, Salvia sagittata Ruiz & Pav and Clinopodium tomentosum Kunth), traditionally used to 
treat different diseases, on primary culture of porcine aortic endothelial cells (pAECs) stimulated 
with Lipopolysaccharide (LPS).  
This approach is relevant in terms of screening possible positive activities of medicinal plants in 
relation to the Replacement and Reduction principles in agreement with the European Directive 
2010/63/EU on the protection of animals used for scientific purposes and its implementation in  
Italy through “Decreto Legislativo“ n. 26/2014.  
Different extraction processes and techniques have been employed to verify their  phytochemical 
and biological effects (HPLC, RT-PCR, Western blot). The phytochemical analysis revealed the 
presence of different bioactive compounds (11-keto-β-boswellic acid and β-boswellic acid in 
Boswellia serrata extracts, different phenolic acids and flavonoids with rosmarinic acid as the 
most abundant component in Salvia sagittata and Clinopodium tomentosum extracts). In the 
biological analysis, Cucumis sativus, Boswellia serrata, Salvia sagittata and Clinopodium 
tomentosum reduced the LPS-induced cytotoxicity with the decrement of different inflammatory 
cytokines and increment of protective molecules and anti-inflammatory cytokines.  
In conclusion, our results have clearly demonstrated that the medicinal plants studied have 
attenuated lipopolysaccharide induced inflammatory response in endothelial cells. Moreover the 
studies confirm the relevance of primary culture of pAECs as an interesting screening model to 



























2.1 Endothelial cells and their role in health and disease 
Endothelial cells, for their strategic position, play a fundamental role in different physiological 
processes such as in inflammatory diseases. Normally, they are in dynamic equilibrium with their 
environment preventing thrombus formation by expression and secretion of anti-coagulant, anti-
adhesive, and anti-inflammatory molecules. 
 
Figure 1. Functions of endothelial cells (Triggle et al. 2012) 
However, under the stimulation of many different stressors, the endothelium shows changes, 
which allow it to participate in the inflammatory response; this phenomenon is known as: 
“endothelial cell activation” (Hunt & Jurd 1998). This term was coined in the 1960s by Willms-
Kretschmer to underline a change in the endothelial morphology as well as in the endothelial 
function. Then, in the 1980s it was demonstrated that interleukin 1 and tumour necrosis factor, 
induced expression of pro-adesive, pro coagulant and inflammatory genes switching the 
endothelial resting phenotype into an activated one. These changes do not necessarily evolve into 
injury or dysfunction, therefore it was reintroduced the term “endothelial cell activation” (Pober 
1988). 
It is now well demonstrated that the phenotype of activated endothelial cells involves the up-
regulation of pro-inflammatory genes, including secretion of inflammatory cytokines and 
chemokines. This state can still be counterbalanced by the synthesis of protective molecules (IkB-




Otherwise the activation of transcription factor NF-kB if not contrast can evolve into apoptosis or 
necrosis of endothelial cells 
Moreover, endothelial cell activation is divided in two distinct stages, an early event named ‘‘EC 
stimulation’’ and a later event named ‘‘EC activation’’. These two phases are referred to as ‘‘Type 
I EC activation’’ and ‘‘Type II EC activation,’’ respectively (Bach 1994; Pober & Sessa 2007; 
Roumenina et al. 2016) 
Figure 2.  Endothelial cell activation (Zhang et al. 2010) 
Type I activation: occurs immediately following stimulation and does not require de novo protein 
synthesis or gene transcription. The surface of the type I-activated ECs is capable of shedding 
endothelial adhesion and antithrombotic molecules, such as P-selectin,thrombin, heparin, 
antithrombin III, and thrombomodulin (Bach 1994).  This activation typically occurs after 
interaction of different ligands that bind to the extracellular domains of heterotrimeric G‑protein-
coupled receptor (GPCRs), as example histamine H1 receptors signal through the intracellular G-




exchange triggers the dissociation of the G-protein αq subunit and activates β isoforms of 
phospholipase C (PLCβ), catalysing the release of inositol‑1,4,5-trisphosphate (InsP3) from the 
membrane lipid phosphatidylinositol‑4,5- bisphosphate (PtdIns (4,5) P2). InsP3 induces transient 
intracellular elevations in cytosolic free Ca2+ by releasing Ca2+ from endoplasmic reticulum 
stores. In endothelial cells, these changes may take the form of oscillatory, transient Ca2+ levels, 
or may, at greater signal strength, produce an elevated plateau of cytosolic Ca2+ levels (Birch et 
al. 1994). The entry of extracellular Ca2+ may be sustain elevated cytosolic Ca2+ levels (Lückhoff 
& Clapham 1992). The exchange of GDP for GTP, on the small G protein RHO (RAS homologue), 
is facilitated by the activation of GPCRs. Thus, the type I activation response is mediated by 
combine RHO activation and elevation in cytosolic free Ca2+. Specifically, Ca2+-mediated 
activation of cellular phospholipase A2 (cPLA2), an enzyme that cleaves membrane 
phosphatidylcholine into arachidonic acid and lysophosphatidylcholine, results in an increased of 
blood flow.  
By cyclooxygenase‑1 (COX1; known as prostaglandin H synthase 1 (PGH1)) the free arachidonic 
acid is rapidly and sequentially converted to PGH2 and then by prostacyclin synthase to PGI2 (Niu 
et al. 2003). The adaptor protein calmodulin form a complex with the cytosolic Ca2+ ions that 
activates nitric-oxide synthase 3 (NOS3) to produce NO, which synergizes with PGI2. The 
formation of Ca2+–calmodulin complex and the temporary rise in cytosolic Ca2+ leads to the 
activation of myosin-light-chain kinase (MLCK) (Egan & FitzGerald 2006), which phosphorylates 
myosin light chain (MLC). The combination of MLC phosphatase inhibition (mediated by RHO-
dependent kinase) and MLCK activation increases MLC phosphorylation. The phosphorylation of 
MLC initiates the contraction of actin filaments that are attached to tight junction and adherens 
junction proteins resulting gaps opening between adjacent endothelial cells. In post-capillary 
venules, these responses are particularly evident where tight junction elements are least expressed 
and relevant GPCRs are maximally expressed (Heltianu et al. 1982). The leakiness of venules may 
be enhanced by the production of NO and PGI2 in venular endothelial cells (Teixeira et al. 1993).  
A provisional matrix formed by plasma proteins, leaking from the blood into the tissues, supports 
the migration, attachment and survival of invading neutrophils (Frangogiannis 2006). 
The exocytosis of WPBs is also causing by the activation of MLC in venular endothelial cells, 
which bring P‑selectin to the luminal cell surface (Birch et al. 1992 and 1994). At the same time, 
an endothelial-cell derived acyl form of platelet-activating factor (PAF) is formed by the rapidly 
acetylation of lysophosphatidylcholine (Prescott et al. 1984). The collective display of P‑selectin 




tethering of circulating neutrophils (due to P‑selectin) followed by cell regulation and integrin 
activation (due to PAF), initiating neutrophil extravasation (Lorant et al. 1991). 
In intracellular Ca2+ rising in endothelial cells also has a major role in leukocyte recruitment. Most 
part of leukocytes seem to cross through the wall vessel by passing between adjacent endothelial 
cells (Marchesi 1961).  
The endothelial cell membranes not only contain adherens and tight junction proteins, but also 
express a platelet-endothelial cell adhesion molecule 1 (PECAM1 or CD31) and, two proteins that 
participate in homophilic interactions with neutrophils and monocytes in a manner that is essential 
for transmigration (Schenkel et al. 2002).  
Occasionally leukocytes also may cross through the endothelial cell body (Feng et al. 1998). 
 
Figure 3. Type I endothelial cells activation phatway (Pober & Sessa 2007). 
Type II activation of endothelial cells. is a delayed response that involves the activation of gene 
transcription and the de novo synthesis of proteins (Pober & Sessa 2007). including adhesion 
molecules, cytokines, chemokines, and procoagulant factors (Bach 1994; Goepfert et al. 2000). 
Typically it is initiated in an inflammatory process that is sustained in the time and requires a more 
persistent form of endothelial cell activation. Tumour-necrosis factor (TNFα) and interleukin‑1 
(IL‑1), derived principally from activated leukocytes, are the principal mediators involved in this 
response (Pober & Cotran 1990). The signalling pathway used by TNF in endothelial cells begin 
when TNF binds to the extracellular domains of TNF receptor 1 (TNFR1) and recruits TNFR-




TRADD in turn recruits the serine/theonine kinase receptor interacting protein 1 (RIP1) and 
TNFR-associated factor 2 (TRAF2), an E3 ubiquitin ligase. This complex, also called as 
signalosome, initiates various kinase cascades that lead to activation of activator protein 1 (AP1) 
and the transcription factors nuclear factor-κB (NF-κB) (Aird 2006). 
On the other hand, the binding of IL‑1 to the type 1 IL‑1 receptor (IL-1R1) induces a signalling 
pathway mediated by a signalling complex comprised of Toll/IL‑1 receptor accessory protein 
(TIRAP), myeloid differentiation primary‑response gene 88 (MyD88), IL‑1R-associated kinase 1 
(IRAK1), IRAK4, and TRAF6, that activates the same transcription factors trigger by TNF (Martin 
& Wesche 2002). The pro‑inflammatory responses induced by these cytokines emerge from new 
gene transcription mediated by AP1 and NF‑κB. Type II activation response require a longer time 
to be initiated (hours) since these responses require both transcription and translation of new 
proteins. Type II activation also leads to increase vascular leakage of plasma proteins, increase 
blood flow and increase leukocyte recruitment at the site of inflammation. Furthermore, due to the 
induction of COX2, type-II-activated endothelial cells enhance PGI2 synthesis, which, as COX1, 
can initiate prostaglandin synthesis by converting arachadonic acid to PGH2 in a much throughput 
higher level. The increase in blood flow, in type-II-activated endothelial cells, still depends on a 
rise in cytosolic Ca2+ produced in type I activation in order to activate cPLA2 and release 
arachadonic acid (Zavoico et al. 1989). 
TNF and IL‑1 induce the leakage of plasma proteins by stimulating venular endothelial cells to 
reorganize their actin and tubulin cytoskeletons and thereby open up gaps between adjacent cells 
(Pober et al. 1987; Petrache et al. 2003). The stimulation of vascular endothelial cells to reorganize 
their actin and tubulin cytoskeletons and thereby open up gaps between adjacent cells, produced 
by TNF and IL-1, results in a leakage of plasma proteins which in turn is triggered in an NF‑κB- 
and protein-synthesis-dependent manner. 
A particularly firm provisional matrix described as an induration (hard swelling), is produced by 
the sustained leakage of plasma proteins, such as fibrinogen, which is converted into a fibrin-rich 
clot and conduce to the hardness (Clark et al. 2007). 
In type II activation the leukocyte recruitment is much more effective than in type I activation. 
The synthesis and display of chemokines, such as CXC-chemokine ligand 8 (CXCL8; also known 
as IL‑8) and new leukocyte adhesion molecules, such as E‑selectin produce the recruitment of 
neutrophils. Endothelial cells can also capture chemokines made by other cells and display them 




firm attachment of neutrophils to endothelial cells and induces diapedesis into the tissue. It can 
only act efficiently on neutrophils that are tethered or rolling on the endothelial cell surface; that 
is, CXCL8 and E‑selectin (Ley & Reutershan 2006).  
 
Figure 4. Type II endothelial cells activation phatway (Pober & Sessa 2007). 
2.2 Endothelial cells and angiogenesis  
Vascular remodeling is an active process that leads to a reorganization of the vascular structure 
also determining functional changes. Remodeling often occurs in response to prolonged 
physiological haemodynamic changes, for example during pregnancy or during physiological 
processes such as wound healing (Klein et al. 2014). However, even pathological conditions, 
including phenomena such as atherosclerosis, thrombosis, hypertension, ischemic diseases, 
congenital vascular lesions (aneurysms, fibromuscular hyperplasia and stenosis) and tumor growth 
are characterized by an increase in vascular reorganization (Korshunov et al. 2007; Mulvany 1999; 
Renna et al. 2013). Vascular remodeling during embryonic life occurs mainly through 
vasculogenesis phenomena, in which the formation of new blood vessels from the differentiation 
of bone marrow-derived endothelial progenitors called angioblasts. In the adult life, the vascular 
remodeling takes place mainly through the phenomenon of angiogenesis, that is the formation of 
new vessels from a pre-existing vascular network. The role of ECs in the angiogenesis is 




cells due to a pro-angiogenic stimuls such as the growth factor “Vascular Endothelai Growth 
Factor” VEGF or the fibroblast growth factor (FGF). EC selected to become the “tip cell” migrates 
and guide the new sprout formation. In particular, the sprouting of new vessel follow a well-
defined program: the degradation of basement membrane by metal proteinases (MMPs) secretion, 
then endothelial cell proliferation and a formation of solid sprouts. New sprouts connect 
neighboring vessels with a lumen lined by endothelial cells and integrated in the vascular network. 
Finally the coverage of pericytes and smooth muscle cells render stable the new vessels (Betz et 
al. 2016).  
 
Figure 5. “Sprouting angiogenesis” (Yoo & Kwon 2013). 
Endothelial cells could made angiogenesis also for a less descripted phenomenon of 
intussusceptive angiogenesis in which a cylindrical microstructure spans the lumen of small 
vessels and capillaries. The extension of the intussusceptive pillar appears to be a mechanism for 
pruning redundant or inefficient vessels, modifying the branch angle of bifurcating vessels and 
duplicating existing vessels (Mentzer & Konerding 2014). The process begins with the protrusion 
of opposing capillary walls into vessel lumen, after establishing an interendothelial contact EC 




girth after being invaded by pericytes and fibroblasts, which produce collagen fibrils (Burri et al. 
2004).  
 
Figure 6.  Intussusceptive angiogenesis  (Burri et al. 2004) 
An out of balance of angiogenesis is the basis of many pathological disorders (Ungvari et al. 2018). 
In particular, excessive angiogenesis is involved in diseases such as cancer, blinding disorders, 
arthritis and sepsis. On the contrary an insufficient angiogenesis occurs in chronic wounds, 
coronary heart diseases, stroke. (Zhang et al. 2013) 
2.3 Secondary metabolites and their role in nature 
Plants have populated the majority of the worldwide surface. They are present, by volume and 
weight, in more proportion than all other forms of life combined owing of rich levels of 
specialization and the capacity to interact with other organisms (Ramakrishna & Ravishankar 
2011). In general plant metabolism is often centered around two major classes. Primary 
metabolism allows the plant to use water, carbon dioxide and minerals to the production of 
macromolecules (carbohydrates, lipids and amino acids) required to cellular creation and 
maintenance.(Kennedy & Wightman 2011). 
Secondary metabolites are molecules that play a major role in the adaptation of plants to different 
environment and stress conditions. At the beginning were considered as compounds without 
fundamental role in the maintenance of life processes in the plants, but an indication of their 
necessity in plants survival is reflected in the energy invested in their synthesis, which is usually 




several straightforward activities; such as, protecting the plant against different microorganisms 
(bacteria, fungi, and viruses), acting as allelopathic defenders of growing space against competitor 
plants and at the same time produce antioxidant and antiproliferative agents. Furthermore, have 
significant practical applications in medicinal, nutritive and cosmetic purposes.(Kliebenstein 
2013). 
2.4 Bioactive compounds from natural sources and drug 
discovery 
Natural products, especially plants, have been used since ancient time for their therapeutic 
properties. Certainly, their use goes back to the Sumerian civilization and even more it has been 
recorded that Hippocrates used approximately 400 different plant species for medicinal purposes. 
Likewise, in different civilizations, such as Chinese, Ayurveda, and Egyptian, natural products 
played a prominent role in ancient traditional medicine systems. Over the last century, an 
impressive number of modern drugs have been derived and developed from natural sources 
(vincristine from Vinca rosea, morphine from Papaver somniferum, Taxol from T. brevifolia) and 
many of them based on their use in traditional medicine (Sarker et al. 2006). According to Cragg 
et al. 1997, 39% of the 520 new approved drugs between 1983 and 1994 were natural products or 
their derivatives, and 60–80% of antibacterial and anticancer drugs were from natural origins. In 
2000, approximately 60% of all drugs in clinical trials for the multiplicity of cancers had natural 
origins. In 2001, eight (simvastatin, pravastatin, amoxycillin, clavulanic acid, azithromycin, 
ceftriaxone, cyclosporin, and paclitaxel) of the 30 top-selling medicines were natural products or 
their derivatives, and these eight drugs together totaled US $16 billion in sales. The emergence of 
‘‘natural’’ pharmaceutical industry, which is growing rapidly in Europe and North America, as 
well as in traditional medicine programs being incorporated into the primary health care systems 
of Mexico, the People’s Republic of China, Nigeria, and other developing countries has done one 
more time becoming popular the use of natural products in the form of food supplements, 
nutraceuticals, and complementary and alternative medicine. Due to the extension of the planet, 
only a small fraction of the world’s biodiversity has been explored for bioactivity to date. As 
example, so far only 5-10 % of the almost 250,000 species of higher plants that exist in the planet 
have been investigated. Additionally, the reinvestigation of previously studied plants has 
continued to produce new bioactive compounds with interesting drug potential. Another valuable 
source for novel bioactive compounds is represented by marine organisms of which few studies 




several new and highly specific in vitro bioassay techniques, chromatographic methods, and 
spectroscopic techniques, especially nuclear magnetic resonance (NMR), have made much easier 
to screen, isolate, and identify potential drug lead compounds quickly and precisely (Sarker et al. 
2006). 
2.5 Phytoterapy in veterinary medicine 
The use of natural products including animals, minerals, and plants for medicinal purpose 
originates even before recorded history. In fact, natural products used to treat different diseases is 
not only restricted to humans but also extended to the treatment of various animal disorders 
(Antonio et al. 2015). Thus, the search to find more effective and affordable medicines to be used 
in the treatment of different diseases in animals, as in the human case, is ongoing. 
McCorkle 1995 defined the ethnoveterinary research as ‘the systematic investigation and 
application of folk veterinary knowledge, theory and practice. Moreover, ethnoveterinary 
medicine (EVM), additionally to the use of ethnoveterinary plants to prevent and control disease, 
includes animal husbandry practices, the use of diagnostic procedures, surgical methods and 
traditional veterinary theory (Schillhorn van Veen 1997; Van der Merwe et al. 2001). 
Despite just very few phytotherapeutic products are registered for animal’s treatment and scientific 
literature relies on few books or manuals regarding veterinary phytotherapy, EVM has attracted 
considerable interest in various parts of the world as attested by a high number of ethnoveterinary 
surveys conducted in Africa, America, Asia, and Europe (Ahmad et al. 2015; Benítez et al. 2012), 
even currently is a major topic in an increasing number of research projects, and the publication 
of studies on EVM, in certain international journals dealing with veterinary medicine or 
pharmacology, are more frequent (Akerreta et al. 2010; Lans et al. 2009). EVM is often the only 
available alternative to rural and suburban populations of the developing countries (McCorkle 
1995; Wanzala et al. 2005) in which having farm animals (donkey, mule, pig or chickens) is fairly 
common, desirable, and probably indispensable for the family economy and in consequence 
looking after the health of these animals is crucial for the family economy. There are also still rural 
communities in Europe, especially in the Mediterranean region, where the health care of the 
members of a family extends to that of their domestic animals. 
To reduce the use of conventional drugs, EVM is utilized in organic farms, in which not only 
herbal drugs, such as plant extracts and essential oils, but also homeopathic products, 
nutraceuticals and oligoelements, are considered the main drugs to administer in different animal’s 




digestive, and cardiovascular affections, and to reduce stress are often utilized in pets, in particular 
by owners that used such remedies for themselves (Severino et al., 2008). 
In addition is important to consider many aspects in the use of medicinal plants in EVM as example 
seasonal unavailability of plant material, methods of preparation and administration of the plant, 
management practices to limit the impact of the disease, as well as lack of dosing certainty and 
standardization of remedies. In consequence, a lack of activity in a laboratory-based in vitro 
screening system does not automatically correspond to lack of efficacy of a traditional medication. 
Obviously EVM is possible to be used in common ailments (mild diarrhoea, skin diseases, 
intestinal worms and wounds) because at the moment orthodox treatments are certainly 
indispensable in cases such as epidemics of contagious diseases (Martin et al. 2001). 
2.6 Animal models for translational medicine 
The translation of theoretical knowledge and experimental breakthroughs into clinical practice of 
medicine is also known as Translational Medicine. Obviously, scientific discoveries prove to be 
complete when they result into an application: usually, a medical discovery follows the path, from 
the “benchside to the bedside” resulting in the so-called Translational Research (Keramaris et al. 
2008). Animal testing places itself exactly in the middle of the process of the Translational 
Research applied to the study of human biology. 
Evidently, the best model to study human biology (physiology, pathology, treatment of diseases) 
would be the human subject, but it is clear that this option cannot be considered ethical. To 
overcome this problem, animals have been routinely used as models to characterize pathogenesis 
of diseases and to discover new drugs, entailing several advantages such as the homogeneity of 
the population and the wider possibilities to study toxicity of treatments, pathology and 
physiology. The evaluation of mechanism of action of existing drugs and the discovery of new 
drugs have been widely carried out using animal models. However, even if the animal is a complex 
and functional model, effective treatments on animals could be less or not effective or, sometimes, 
even harmful on humans (Hooijmans & Ritskes-Hoitinga 2013; McGonigle & Ruggeri 2014). The 
main challenges in Translational Research consist in the biological differences among species, the 
poor methodological quality of animal experiments, the differences in designing the experiments 
that involve animals, as well as the deficient reporting of the details concerning the animal 
experimentation (Hooijmans & Ritskes-Hoitinga 2013).  
Scientists are always committing to the continuous challenge faced by the translational research 




reviews of animal experiments” written by Sandercock and Roberts. This paper strongly 
recommended the systematic review of the literature concerning well performed animal 
experiments (high quality methodology) as the base of any new clinical trial (Sandercock & 
Roberts 2002). It is quite clear that the high-quality methodology (Russell and Burck’s 
Refinement) is essential to improve the outcome of a translational research. The urgent need for 
guidelines in animal experiments was also underlined in the Kilkenny and colleagues’ paper. After 
a survey on a consistent number of scientific papers concerning animal testing, the authors reported 
a lack of some of the major information about the experiments that involve animals and 
recommend an accurate and transparent description of the methods (Kilkenny et al. 2009). In their 
following articles, they also defined the Animal Research Reporting In Vivo Experiments 
(ARRIVE) guidelines as a tool for animal-based experimentation (Kilkenny et al. 2010; 
Hooijmans & Ritskes-Hoitinga 2013; Dothel et al. 2013), available on the web 
(https://www.nc3rs.org.uk/arrive-guidelines) and actually required by many relevant biological 
journals for publications of animal experiments. 
2.7 Use of medicinal plants in Ecuador 
The number of vascular plants that exists on Earth varies according different estimations between 
260,000 and 320,000 species (Bennett & Prance 2000; Judd et al. 2002). The vast majority of them 
are plants with flowers or angiosperms, which appeared in the Cretaceous 145 million years ago 
(Judd et al. 2002). Adaptations of plants for life in firm ground formed the basis for the 
development of human, who has populated the entire planet and has obtained from plants the 
sustenance necessary to survive. The more than 17,000 species of vascular plants that exist in 
Ecuador (Jørgensen & León-Yánez 1999, Ulloa Ulloa & Neill 2005) are the result of a history of 
adaptations to diverse means, coevolution with other organisms and the dynamics of the earth's 
surface. This great diversity of Ecuadorian plants comes from own species of the Tropical Andes, 
of tropical and subtropical zones of America, tropical Asia, Malaysia, Africa, as well as from 
temperate zones of the northern and southern hemispheres, even from the cold regions of the 
austral element, as the sub-Antarctic and Antarctic and of cosmopolitan plants (Gentry 1990, Ulloa 
Ulloa & Jørgensen 1995). The quarter of the Ecuadorian species are endemic (Valencia et al., 
2000) and of these, 7% have been reported to be useful in different applications.  
The first inhabitants used plants to fed (roots, seeds, stems and fruits) and probably obtained spices 
or condiments as a food supplement. In addition to treat their ailments, infestations and diseases, 




to hunt, fish and even, to kill his enemies. They identified what woods burned better as fuel and 
which ones were optimal for the construction of boats and shelters. They learned the extraction of 
natural fibers to knit goods for the transport of food and to manufacture textiles. They also learned 
the properties of stimulating plants as yocó (Paullinia yoco) and the guayusa (Ilex guayusa) Also 
of those as yaje (Banisteriopsis caapi), San Pedro (Echinopsis pachanoi), wantuk (Brugmansia 
sanguinea) or vilca (Anadenanthera colubrina), that could lead them to altered states of 
consciousness, to explore the metaphysical world and communicate with spirits and gods that were 
part of his worldview. In summary, the immense diversity of plants with which the human being 
interacted in the different Ecuadorian ecosystems, were fundamental pillar of current cultures. 
Traditional knowledge and the use of wild plants is being lost, so the acculturation process is 
occurring rapidly and silently in Ecuador (Byga & Balslevb 2004, Guerrero 2005). Scientific 
research is a basic instance that has the power to influence beneficially the interaction of man with 
the plants at different scales and who can contribute notably to this new social reality, as it provides 
guidelines for the sustainable use of species and ecosystems and provides objective approaches 
when carrying out actions or make conservation decisions or modes of exploitation of species.  
The use of medicinal plants is immersed in the daily life of its inhabitants. Folk medicine is 
practiced mainly by inhabitants of rural areas, but also by persons of all social classes. In markets 
of the Sierra, Coast and Amazon is possible to find a variety of plants with medicinal uses (Ortega 
1988, Cerón & Gaybor 1994, Cerón & Montalvo 1994). The causes that accentuate the extensive 
employment of medicinal plants among Ecuadorians are: the low purchasing power of the majority 
of the population that does not allow to access to medicines, the lack of an official health system 
effective and, mainly, because the medical ancestral knowledge ancestral is immense (Estrella 
1995, Buitrón 1999). Because of the Spanish conquest that took place in the XVI century and the 
constant coming and going of diverse people, have been incorporated new medicinal elements that 
have been amalgamated and have enriched the ancestral indigenous medical knowledge (Varea 
1922, Acosta-Solís 1992b, Buitrón 1999). In traditional Ecuadorian medicine, the real and the 
magical world (populated by spirits, gods and demons) are the both sides of the medal. In this 
context, the diseases are not consequences of the failures of the organs and their functions, or the 
invasion of pathogens, but the result of the influences of external and supernatural forces that are 
behind of all things of the real world, to warn, reward or punish according to their codes, mandates, 
interests or sympathies (Kohn 1992b, Kothari 1993, Rodríguez 1995). As in other countries, it is 
important and characteristic the use of psychotropic agents for healing through rituals (Schultes & 




transmitted only in oral form and that is why it becomes indispensable to improve the research in 
this field in Ecuador, with the aim to conserve in a better way the species and their habitats, 













































The present research was performed in the Dipartimento di Scienze Mediche Veterinarie of the 
University of Bologna, Dr Tubon Usca participate to the research activities thanks to a special 
scholarship offered by Secretaría de Educación Superior, Ciencia, Tecnología e Innovación 
(Ecuador)  
Principal aims were: 
• To isolate and characterize primary cultures of porcine aortic endothelial cells (pAECs). 
• To characterize, by high Performance Liquid Chromatography (HPLC), different 
medicinal plant extracts used in the traditional medicine. 
• To analyze by biological tests the anti-inflammatory activity of different medicinal plants 
on porcine aortic endothelial cells (pAECs) in order to find scientific arguments that support their 
traditional uses. 
• To demonstrate the importance of the study of medicinal plants, especially in countries 
with high biodiversity, to contribute with the development of the scientific knowledge and improve 
the quality life and health of the people. 
In this framework four medicinal plants, Cucumis sativus, Boswellia serrata, Salvia sagittata and 






































4.1 Cell isolation characterization and use  
Thoracic aortic traits were collected from adult pigs at a local slaughterhouse. After collection, 
aortas were firstly washed with a sterile sodium chloride physiological solution contained 
ampicillin and amphotericin B and then with Dulbecco Phosphate Buffer Solution (Gibco-Life 
technologies Carlsbad CA, USA) contained antibiotics-antimicotics 10X (Gibco-Invitrogen). 
After that aorta was cleaning by cutting the excess of material adhered to the arterial branches. 
Then all the arterial side branches were tied, and aorta was canulated with modified syringe 
cones to set up a closed system. The vessels were gently flushed with a solution of DPBS 
containing antibiotics-antimicotics 1X (antibiotic-antifungal) to remove residual blood, then 
was filled with DPBS added with 0.2% collagenase (Sigma Chemical Company, St Louis, MO, 
USA) and clamped at both ends. After 20 minutes of incubation at 38,5°C, the collagenase 
solution was collected, and the vessels were washed with DPBS containing 10% of fetal bovine 
serum (FBS) (Gibco-Life technologies Carlsbad CA, USA). The solutions were pooled and 
centrifuged at 500 g for 10 minutes. The cellular pellet was resuspended in 1 mL Human 
Endothelial Serum Free Medium (hESFM) (Gibco-Life technologies Carlsbad CA, USA) 
supplemented with 10% of FBS and 1% antibiotics-antimicotics (Gibco-Invitrogen). Cell 
number and viability (85–90%) were determined under a phase-contrast microscope. 
Approximately 3x105 cells was placed in T-25 tissue culture flasks (T25-Falcon, Becton-
Dickinson, Franklin Lakes, NJ, USA) in a 5% CO2 atmosphere at 38.5°C. The cells were 
maintained in a logarithmic growth phase by routine passages every 2–3 days at a 1:3 split ratio. 
To confirm their endothelial origin, cultured cells were grown in slide chambers (Falcon, 
Becton-Dickinson) for 24 hours, they were then fixed with ethanol:acetic acid (2: 1) and stained 
with 1:200 rabbit polyclonal anti-human factor VIII (Dako A/S, Glostrup, Denmark), 1:100 
mouse monoclonal anti-porcine CD31 (Serotec LTD, Oxford, UK), and 1:25 rat monoclonal 
anti-porcine Caderine (Serotec LTD) antisera. Primary antibodies were added in a humidified 
chamber for 1 hour at room temperature (RT); fluorescein isothiocyanate (FITC)-conjugated 
secondary antibodies were then added (1:800 dilution in DPBS). The cells were then 
counterstained with propidium iodide and examined under an epifluorescence microscope 
(Eclipse E600 Nikon, Japan) equipped with fluorescein (FITC) and tetramethylrhodamine 











4.2 Cucumis Sativus  
Bernardini C, Zannoni A, Bertocchi M, Tubon I, Fernandez M, Forni M. Water/ethanol extract of 
Cucumis sativus L. fruit attenuates lipopolysaccharide-induced inflammatory response in endothelial 






























































4.3 Boswellia serrata 
Martina Bertocchi, Gloria Isani, Federica Medici, Giulia Andreani, Irvin Tubon Usca, Monica Forni, 
Chiara Bernardini. “Anti-Inflammatory Activity of Boswellia serrata Extracts: An In Vitro Study on 



















































4.4 Salvia sagittata 
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Abstract 
The aim of the present research was to study the effects of an ethanolic extract of Salvia sagittata 
Ruiz & Pav (SSEE), an endemic Ecuadorian plant traditionally used to treat inflammation and 
different intestinal affections, on primary cultures of porcine aortic endothelial cells (pAECs).  
pAECs were cultured in the presence of different concentrations (1-200 µg/mL) of SSEE for 24 h 
and cytotoxicity was evaluated by the MTT assay. SSEE did not negatively affect cellular viability 
at any concentration tested. Cell cycle was analyzed and no significant change was observed. Then, 
the anti-inflammatory effects of SSEE on pAECs were analyzed using Lipopolysaccharide (LPS) 
as the inflammatory stimulus. Different markers involved in the inflammatory process, such as 
cytokines and protective molecules, were evaluated by the MTT assay, Real-Time quantitative 
PCR (RT-qPCR) and Western blot. SSEE showed the ability to restore pAECs physiological 
conditions reducing IL-6 and increasing HO-1 protein levels. The phytochemical composition of 
SSEE was also evaluated by HPLC-DAD and spectrophotometric assays. The presence of different 
phenolic acids and flavonoids was revealed, with rosmarinic acid as the most abundant component. 
SSEE possess an interesting antioxidant activity, as assessed through both Oxygen Radical 




In conclusion, results suggest that SSEE is endowed with an in vitro anti-inflammatory effect. This 
represents the initial step in finding a possible scientific support for the traditional therapeutic use 
of this plant.  
1. Introduction 
In the last years, researches aimed to scientifically define the effects of natural products have been 
growing, not only due to the increasing popularity of the plant-based Traditional Medicine, but 
also because it provides the primary health-care needs for the majority of the population in 
developing countries [1]. Moreover, a huge number of medicinal plants, not still investigated, are 
available worldwide. Currently, more than 20.000 plant species are used to treat several diseases 
and are considered as potential reservoirs for new drugs [2]. Recent studies suggest that the 
historical ethnopharmacological uses of plant-based medicines can represent a useful preliminary 
screening tool in the field of drug discovery [3]. 
Ecuador is considered one of the countries with the largest biodiversity in the world. The flora of 
mainland Ecuador is extremely rich: an estimated total of 17.000 species have so far been recorded 
[4,5], and more than 3000 medicinal plants are used in different native communities living on the 
highlands of Ecuadorian Andes [6]. However, in most cases, the preparation, doses and route of 
administration of these herbal remedies are only transferred orally from generation to generation, 
while scientific information regarding their phytochemical or biological activity is insufficient or 
lacking at all [7]. 
Salvia L. (sage) is widely known as the largest genus in the Lamiaceae family, and to date, 
approximately 980 species have been recognized, most of which are restricted to the New World 
[8]. Some species of this genus have been used since ancient times as medicinal plants all around 
the world [9-11]. In addition, chemical constituents of various sage plants were described and 
comprise different terpenoids, several phenolic compounds, such as simple phenolics and caffeic 
acid derivatives, flavonoids, as well as phenolic diterpenoids [12]. 
Salvia sagittata Ruiz & Pav is an herbaceous perennial plant distributed in Ecuador and Peru. It 
has yellow-green arrow-shaped leaves and very sticky inflorescences in the apical part of the plant, 
formed by brilliant blue flowers with a prominent lower lip. Its leaves are commonly prepared 
either in infusion to counteract different affections such as spasms, diarrhea, flatulence, fever, 
influenza, gastritis, stomach pain, cuts and bumps, or heated with brandy and applied topically to 




multiple beneficial health effects of S. sagittata, scientific evidences from in vivo or in vitro studies 
are still lacking.  
In order to test the possible biological activity of S. sagittata ethanolic extracts (SSEE), we used 
endothelial cells as model system, given their fundamental role in different physiological 
processes. These cells are normally in dynamic equilibrium with their environment, preventing 
thrombus formation by the expression and secretion of anti-coagulant, anti-adhesive, and anti-
inflammatory molecules. Nevertheless, in pathologic processes, such as inflammation, infection 
or genetic alterations, endothelial cells change their phenotype from a resting to an active function 
that modulates the complement and coagulation cascades, thrombus formation, inflammation and 
innate and adaptive immunity [16,17]. Endothelial cells are also recognized as key regulators of 
the inflammatory response controlling adhesion and migration of inflammatory cells as well as 
resolution of inflammation [18]. 
Tests were carried out on a primary culture instead of cell line model. Despite their viability and 
unlimited expansion, cell lines do not preserve various of the important markers and functions 
shown in vivo [19,20]. On the contrary, primary cells preserve most of these functions. In this 
context, primary cultures of porcine aortic endothelial cells have been used as a suitable in vitro 
model of human ones [21-23], due to the biological similarities between swine and human at 
anatomic [24], proteomic [25] and genomic level [26].  
In this context, we decided to evaluate SSEE for its phytochemical, antioxidant and anti-
inflammatory characteristics as related to biological activities in primary cultures of porcine aortic 
endothelial cells stimulated with bacterial lipopolysaccharide. 
2. Materials and methods 
2.1 Chemicals and reagents  
Human Endothelial Serum Free Medium (hESFM), heat inactivated fetal bovine serum (FBS), 
antibiotic-antimycotic, dulbecco’s phosphate buffered saline (DPBS), phosphate buffered saline 
(PBS) were purchased from Gibco-Life technologies (Carlsbad CA, USA). Propidium iodide (PI) 
was purchased from Miltenyi Biotec (Bergisch Gladbach, Germany). RNaseA/T1 was purchased 
from Thermo Scientific (Waltham, MA, USA). Trizol reagent was purchased from Thermo Fisher 
Scientific (Rockford, IL, USA), RNA isolation was performed with NucleoSpin RNA II kit 
(Macherey-Nagel GmbH & Co. KG, Düren, Germany), iScript cDNA synthesis kit and iTaq 
Universal SYBR Green Supermix were used for cDNA synthesis and qPCR analysis, respectively 




diphenyltetrazolium bromide (MTT) was purchased from Sigma Chemicals Co, St. Louis, Mo., 
USA. Folin-Ciocalteu’s phenol reagent, 1,1-diphenyl-2-picrylhydrazyl (DPPH), 6-hydroxyl-
2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox), 2,2-Azobis(2-methylpropionamidine) 
dihydrochloride (AAPH), fluorescein, gallic acid, rutin, phenolic acids (4-hydroxybenzoic, 
caffeic, chlorogenic, ferulic, gallic, p-coumaric, synapic, syringic, trans-cinnamic, rosmarinic 
acids), quercetin, quercetin-3-O-glucoside, quercetin-3-O-ramnoside, quercetin-3-O-galactoside, 
kaempferol, kaempferol-3-O-rutinoside, hesperetin, hesperidin pure standards (>99.5% purity) in 
powder form, and  HPLC-grade solvents were purchased from Sigma-Aldrich Italia (Milan, Italy). 
All standards were prepared as stock solutions at 1 mg/mL in methanol and stored in the dark at -
18 °C for less than three months. 
2.2 Preparation of plant extract 
Salvia sagittata Ruiz & Pav (SS) plants were collected, according to previous authorization of 
Ministry of the Environment (Nro. 003-IC-DPACH-MAE-2018-F), in Riobamba Ecuador on May 
2016. The plants were identified and certified by Escuela Superior Politecnica de Chimborazo 
Herbarium, Riobamba, Ecuador and a voucher specimen was deposited (N. 3342). Dried leaves 
(300 g) were ground and extracted with 96% ethanol for 48 h at room temperature. After filtration, 
the solvent was evaporated using a rotary vacuum evaporator (Büchi Ch-9230 Flawil, Switzerland) 
and dried in vacuum at 40 °C to obtain EtOH extract with a yield of 6.18%. For experiments, the 
dry extract was dissolved in ethanol. The stock solution (20 mg/mL) was further used for HPLC 
analysis or diluted in culture media and membrane filtered by a 0.2 µm Millipore filter (Millipore, 
Darmstadt, Germany). 
2.3 Cell culture and treatments 
Porcine aortic endothelial cells (pAECs) were isolated and maintained as previously described by 
Bernardini et al. [27]. For the experiments, cells from the third to the tenth passage were used. 
Cells were seeded and routinely cultured in T25 tissue culture flasks (4x105 cells/flask) (T 25-
Falcon, Beckton-Dickinson, Franklin Lakes, NJ, USA). Successive experiments were conducted 
in 96-well plates (cell viability and anti-inflammatory test) or 24-well plates (qPCR and Western 
blot) (both by Beckton-Dickinson) at confluent cultures. Cells were cultured in hESFM, added 
with 5% FBS and 1x antimicrobial/antimycotic solution in a 5% CO2 atmosphere at 38.5°C.  
The SSEE stock solution was diluted in culture medium to obtain desired concentrations (1 – 200 




2.4 Cell viability 
Viability was determined using MTT assay.  Briefly, pAECs were seeded in 96-well culture plates 
at a density of 3 × 103 cells/well and incubated for 24 h. Then, media were replaced with hESFM 
containing 5% FBS and increasing SSEE doses (1, 10, 50, 100 and 200 µg/mL), and incubated for 
another 24 hours at 38.5°C. Next, MTT solution (5 mg/mL in PBS) was added to a final 
concentration of 0.5 mg/mL and then incubated for 2 hours at 38.5°C, followed by the addition of 
0.1 mL MTT solubilisation solution. The formazan Abs was determined at 570 nm, using Infinite® 
F50/Robotic absorbance microplate readers from TECAN Life Sciences (Männedorf, 
Switzerland).  
2.5 Cell cycle 
After defrosting and growing to 80% of pAECs confluence, flask media were replaced with 
hESFM containing 5% FBS and increasing SSEE doses (1, 10, 50, 100 µg/mL). After 24 hours, 
pAECs were harvested, washed once in 5 ml of PBS and 1 mL /106cells of 70% ice-cold ethanol 
was added drop-by-drop with continuous vortexing. The single cell suspension was fixed at 4°C 
for 24 hours. Then, the cells were washed with 10 ml of PBS and cellular pellet was treated with 
1 mL/106cells of staining solution containing PBS, 50 µg/mL of PI and 100 µg/mL RNaseA/T1 
for 20 min in the dark at r.t. Cell distribution in cell cycle phases was analyzed by MACSQuant® 
Analyzer10 and Flowlogic software (Miltenyi Biotec, Bergisch Gladbach, Germany). Dean-Jett-
Fox Univariate Model was used for this analysis. 
2.6 In vitro tube formation assay 
The experiments were carried out using a 8-slide-chamber glass (BD Falcon Bedford, MA, USA) 
coated with undiluted Geltrex™ LDEV-Free Reduced Growth Factor Basement Membrane 
Matrix. Firstly, extracellular matrix coating was carried out 1 hour before the seeding in a 
humidified incubator, at 38.5°C and 5% CO2. Then pAECs (8x10
4 cells/well) were seeded with 
increasing SSEE doses (1, 10, 25, 50 and 100 µg/mL) for 18 h. 
At the end of experimental time, images were acquired using a digital camera installed on a Nikon 
contrast phase microscope (Nikon, Yokohama, Japan) and analyzed by open software Image J 64. 
2.7 Cell viability after LPS treatment 
Briefly, pAECs were seeded in 96-well culture plates at a density of 3×103 cells/well and incubated 
for 24 h, then exposed to different SSEE concentrations (1, 10 and 100 µg/mL) in presence of LPS 




MTT solution was added to a final concentration of 0.5 mg/mL and then incubated for 2 hours at 
38.5°C followed by the addition of 0.1 mL of dimethyl sulfoxide to dissolve the MTT-formazan. 
The amount of MTT-formazan was then determined by measuring Abs at 570 nm.  
2.8 Quantitative real time PCR for IL-6, IL-8, HO-1 
pAECs were seeded in a 24 wells plate (approximately 4x104 cells/well), incubated until 
confluence and then exposed to different concentrations of SSEE (1, 10 and 100 µg/mL) in 
absence or presence of LPS (25 µg/mL). RNA extraction was performed using Trizol reagent 
and NucleoSpin RNA II kit. After 24 h, cells were harvested and lysed using 1 mL Trizol reagent 
and mixed by vortex (3 min) then 200 uL of chloroform was added to the suspension and mixed 
well. After incubation at room temperature (10 min), samples were centrifuged (12000 g for 10 
min) and the aqueous phase was recovered. An equal volume of absolute ethanol (99%) was 
added and the resulting solution was applied to the NucleoSpin RNA Column. RNA was then 
purified according to the manufacturer's instructions. After spectrophotometric quantification, 
total RNA (250 ng) was reverse-transcripted to cDNA using the iScript cDNA Synthesis Kit in 
a final volume of 20 μL.  
Swine primers were designed using Beacon Designer 2.07 (Premier Biosoft International, Palo 
Alto, CA, USA). Primer sequences, expected PCR product lengths and accession numbers in the 
NCBI database are shown in Table 1.  
To evaluate gene expression profiles, quantitative real-time PCR (qPCR) was performed in CFX96 
thermal cycler (Bio-Rad) using a multiplex real time reaction for reference genes (GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; HPRT, hypoxanthine guanine phosphoribosyl 
transferase; β-Actin), and using Taq-Man probes and SYBR green detection for target genes (IL-
6, interleukin-6; IL-8, interleukin-8; HO-1, Heme Oxigenase-1). All amplification reactions were 
performed in 20 μL and analyzed in duplicates (10 μL/well). Multiplex PCR contained: 10 μL of 
iTaqMan Probes Supermix (Bio-RAD), 1 μL of forward and reverse primers (5 μM each) of each 
reference gene, 0.8 μL of iTaq-Man Probes (5 μM) of each reference gene, 2 μL cDNA and 2.6 
μL of water. The following temperature profiling was used: initial denaturation at 95°C for 30 
seconds followed by 40 cycles of 95°C for 5 seconds and 60°C for 30 seconnds. 
The SYBR Green reaction contained: 10 μL of IQSYBR Green Supermix (Bio-RAD), 0.8 μL of 
forward and reverse primers (5 μM each) of each target gene, 2 μL cDNA and 7.2 μL of water. 




°C for 15 s, and 60 °C for 30 s, followed by a melting step with ramping from 55 °C to 95 °C at a 
rate of 0.5°C/10 s.  
The specificity of the amplified PCR products was confirmed by agarose gel electrophoresis and 
melting curve analysis.  
The relative expressions of the studied genes were normalized based on the geometric mean of 
the three reference genes. The relative mRNA expression of tested genes was evaluated as fold 
of increase using the 2-ΔΔCT method [28] referred to pAECs cultured under standard condition 
(control). 
 
Table. 1 Primer sequences used for quantitative real-time polymerase chain reaction analysis. 
2.9 Western Blot for HO-1 
pAECs, treated in the same manner as mentioned above, were washed twice with ice-cold PBS, 
harvested and lysed in SDS solution (Tris-HCl 50 mM pH 6.8; SDS 2%; glycerol 5%). After 
quantitative determination of protein content by a Protein Assay Kit (TP0300, Sigma), aliquots 
containing 20 μg of proteins were separated on NuPage 4-12% bisTris Gel for 45 min at 200 V 
and electro-transferred onto a nitrocellulose membrane. Blots were washed in PBS and protein 
transfer was checked by staining the nitrocellulose membranes with 0.2% Ponceau Red. After 
blocking nonspecific binding with 5% non-fat milk in PBS-T20 (PBS-0.1% Tween-20) at r.t. 
for 1 h, membranes were incubated with a 1:1000 dilution of anti-HO-1 rabbit polyclonal 
antibody (SPA 896 StressGen Biotecnologies Corp, Victoria BC, Canada) overnight at 4 °C. 















































After several washings with PBS-T20, membranes were incubated with the secondary biotin-
conjugate antibody and then with a 1:1000 dilution of an antibiotin horseradish peroxidase 
(HRP)-linked antibody. The Western Blots were developed using chemiluminescent substrate 
(Clarity Western Substrate, BioRad) according to the manufacturer’s instructions. The intensity 
of the luminescent signal of the resultant bands was acquired by Fluor-S TM Multimager using 
Quantity One Software (Bio-Rad).  
In order to normalise the HO-1 data on the housekeeping protein, membranes were stripped and 
re-probed for housekeeping β-tubulin (1:500 sc-5274 Santa Cruz Biotechnology Inc, Santa 
Cruz, CA, USA). The relative protein content (HO-1/β-tubulin) was expressed as arbitrary units 
(AUs). 
2.10 Antioxidant activity assays 
Antioxidant activity (AA) of SSEE was measured by the ORAC and DPPH assays. ORAC assay 
was performed in an automated plate reader (Victor 3, Perkin Elmer, Turku, Finland) with 96-well 
plates, according to Ou et al. [29] with some modifications. All reagents were freshly prepared 
before the assay. In each well, 210 µl of fluorescein (10 nM) and 35 µl of sample, blank (10 mM 
phosphate buffer, pH 7.4), or standard (Trolox in the range 1-50 µM) were placed. The plate was 
heated to 37°C for 10 min, and then 35 µl of AAPH (240 mM) were added, immediately before 
beginning fluorescence (FL) measurement. Relative FL intensity was monitored at 1.5 min 
intervals until it was less than 5% of the value of the initial reading. Final ORAC values were 
calculated by using a regression equation between the Trolox concentration and the net area under 
the FL decay curve and were expressed as mmol Trolox equivalents per g of extract or per g of 
plant material (D.W.). 
DPPH assay was done according to the method of Brand-Williams et al. [30] with some 
modifications. A stock solution was prepared by dissolving 24 mg DPPH with 100 mL methanol 
and then stored at -20°C until needed. The working solution was prepared by mixing 10 mL stock 
solution with 45 mL methanol to obtain an Abs of 1.1±0.02 units at 515 nm. 150 µL of SSEE were 
allowed to react with 2850 µL of the DPPH solution for 24 h in the dark. Abs measurements were 
carried out at 515 nm. Results were determined from the regression equation of Trolox calibration 
curve in the range 25-500 µM, and expressed as mmol TE per g of extract or per g of plant material 
(D.W.). 




Total Phenol Content (TPC) was determined using the Folin–Ciocalteu method [31]. 50 µL of 
diluted extract were mixed with 250 µL of a ten-fold-diluted Folin–Ciocalteu phenol reagent. After 
1 min, 800 µL of 30% sodium carbonate solution were added to the mixture, shaken thoroughly 
and diluted to 1.6 mL by adding 500 µL of distilled water. The mixture was allowed to stand for 
40 min at r.t. and the blue colour formed is measured at 700 nm using a UV-VIS spectrophotometer 
(V-630 Jasco, Jasco Europe S.r.l., Cremella, Italy). A calibration curve of gallic acid (ranging from 
5 to 500 µg/mL) was prepared and results, determined from regression equation of the calibration 
curve, were expressed as mg of Gallic Acid Equivalents (GAE) per g of extract or per g of plant 
material (D.W.). 
Total Flavonoid content (TFC) was determined according to Zhishen et al. [32] with some 
modifications. 500 µL of extract were diluted to 5 mL with distilled water, 300 µL of 5% NaNO2 
were added and the mixture was mixed well. After 5 min, 3 mL of a 10% AlCl3 solution were 
added. After 6 min, 2 mL of 1 M NaOH solution were added, and the total volume was made up 
to 10 mL with distilled water. Absorbance was measured against a blank at 510 nm. Rutin was 
used as standard for the calibration curve. TFC was calculated using the regression equation based 
on calibration curve, and results were expressed as mmol of Rutin Equivalents (RE) per g of extract 
or per g of plant material (D.W.). 
2.12 HPLC-DAD determination of phenolic acids and flavonoids  
20 µL of SSEE were injected into the HPLC system (Jasco Italy; PU-4180 pump, MD-4015 PDA 
detector, AS-4050 autosampler). The stationary phase was an Agilent (Santa Clara, CA, USA) 
Zorbax Eclipse Plus C18 reversed-phase column (100 mm x 3 mm I.D., 3.5 µm). The 
chromatographic method for the analysis of phenolic acids was adapted from Mattila and 
Kumpulainen [33]. Gradient elution was carried out with a mixture of acidic phosphate buffer (50 
mM, pH 2.5) and acetonitrile flowing at 0.7 mL/min. Signals at 254, 280 and 329 nm were used 
for analyte quantitation. The recovery values of phenolic acids in spiked samples ranged from 78.8 
to 92.2% (RSD < 9.8%, n = 6). The chromatographic method for the analysis of flavonoids was 
adapted from Wojdyło et al. [34]. Gradient elution was carried out with a mixture of 4.5% formic 
acid and acetonitrile. Runs were monitored at 280 nm for flavan-3-ols and 360 nm for flavonol 
glycosides.  Retention times and spectra were compared with those of pure standards. Calibration 
curves were constructed for all standards at concentrations ranging from 1.0 to 100.0 ppm (r2 ≤ 
0.9998). Results are expressed as mg/g extract or per g of plant material (D.W.). 




Each treatment was replicated three or eight times (viability and anti-inflammatory test) in three 
independent experiments. Data were analysed by a one-way analysis of variance (ANOVA) 
followed by the post hoc Tuckey comparison Test. Differences of at least p < 0.05 were considered 
significant. Statistical analysis was carried out using Graph Pad Prism 7 software. 
4. Results and discussion 
4.1 Effect of SSEE on pAECs viability and angiogenesis 
A large number of plants of the Ecuadorian flora are used for medicinal purposes. Nevertheless, scientific 
evidences supporting their use are still scarce. For this reason, a study was planned on the anti-angiogenic 
and antioxidant activity, and on phytochemical composition of Salvia sagittata, an endemic plant used in 
Ecuadorian Traditional Medicine. This choice was corroborated by the fact that several Salvia species were 
demonstrated to possess a protective effect against different external agents [35, 36]. 
Based on the traditional uses of the plant, it was decided to focus the biological tests on anti-
inflammatory activity. A preliminary screening aimed at verifying safety of SSEE was carried out  
[37]. Treatment of pAECs with SSEE for 24 hours did not negatively affect cell viability at any 
concentration tested (Fig. 1a). Cells possessed a standard cell cycle for diploid cells (data not 
shown). Thus, SSEE does not seem to induce any cytotoxicity effect on pAECs. These results are 
in agreement with other researches in which different Salvia species did not affect cell viability 
[38]. After this preliminary assay, pAECs’ angiogenesis was examined by an in vitro extracellular 
matrix-based assay. As a result, the capacity of cells to assemble a tube network formation was 





Figure 1. Effects of SSEE on pAECs physiology. Cells were treated with different concentrations of SSEE 
for a) 24 hours for cells viability and b) 18 h for angiogenesis. Cells network formation were recorded at 6 
h and 18 h after treatment (c). Data shown are representative of 8 (a) or 3 (b) replicates in at least three 
independent experiments. Each bar represents mean ± S.D. Different letters above the bars indicate 
significant differences (p < 0.05).  
4.2 Effect of SSEE on LPS-induced cell death and cytokine expression 
Inflammation and endothelial cells are closely related. In fact, in an inflammatory process, 
endothelial cells trigger the transcription of genes such as TNFR or TLR4 that activates the NF-
kB pathway and induces the expression of adhesive receptors (VCAM- 1, E-selectin, ICAM- 1), 
procoagulant proteins (TF, PAI-1), cytokines, chemokines and protective proteins [17]. 
Therefore, the anti-inflammatory activity of SSEE on pAECs was evaluated by an endothelial 




effect against LPS damage through a MTT assay. LPS exerted an evident cytotoxic effect, 
producing a significant 20% reduction of pAECs viability (Fig. 2a) SSEE significantly reduced 
LPS-induced cytotoxicity, restoring the basal levels at 100 µg/mL concentration (Fig. 2a).   
Given the well documented relationship between the inflammation process and the oxidative 
stress [41], the in-vitro antioxidant activity (AA) of the extract was evaluated by two assays, 
based on two different mechanisms: the ORAC assay, which is based on hydrogen-atom transfer 
(HAT) mechanism, and the DPPH assays, which is an electron transfer assay. As it can be seen 
from Table 2, the AA values of the extract were rather similar in the two assays, being 0.10 and 
0.11 mmol TE/g DW, respectively. Even though it is extremely difficult to compare and to 
interpret data on AA of plant extracts, due to the wide number of factors affecting the activity 
(extract preparation procedure, test method used, etc.), the values of the extract resulting from 
both DPPH and ORAC assays were very close to those reported for other crude plant extracts 
prepared in a similar way [42]. 
Table 2. Antioxidant Activity (AA), TPC, TFC, phenolic acids and flavonoid content in SSEE. Data 
are the mean ± S.E. of three technical determinations 
Assays or 
Compounds 









































Antioxidant activity and protective effect of SSEE against LPS might confirm its anti-
inflammatory activity and justify one the traditional Salvia sagittata uses. Nevertheless, to gain 
insight into the molecular mechanisms involved in mediating these responses, it was decided to 
investigate how SSEE could influence some of the main inflammatory markers and protective 
molecules expressed by endothelial cells at both transcription and proteomic level.  
IL-6 and IL-8 are stress-responsive proinflammatory chemokines that play a pivotal role in the 
pathogenesis of different acute inflammatory conditions [43, 44]. They can be synthesized by 
different cell types; IL-6 activates the differentiation of cytotoxic T cells and monocyte and 
induces angiogenesis and increases vascular permeability [45, 46], while IL-8 is a potent 
chemoattractant and activator of leukocytes and fibroblasts and is closely associated with 
endothelial permeability, inflammatory recruitment, and release of pro-inflammatory mediators 
[47]. 
As can be seen in Fig. 2b, 2 c, LPS induced a significant increase of both IL-6 and IL-8 mRNA 
expression after 24 h of treatment. SSEE at all tested concentrations was able to revert the LPS-
induced increase of IL-6 gene expression (Fig. 2b), and to revert that of IL-8 in the 1-10 µg/mL 
range (Fig. 2c).  
 
Figure 2. Effects of SSEE on LPS-induced pAECs damage. a) Effect of SSEE on LPS-induced 
cytotoxicity. Each bar represents mean ± S.D. Effect of SSEE on b) IL-6 and c) IL-8 mRNA expression. 
Relative expression (RE) was calculated as fold of change in respect to the control cells and error bars 




independent experiments. Different letters above the bars indicate significant differences (p < 0.05 
ANOVA post hoc Tukey’s test). 
This is in agreement with other in vivo and in vitro reports on other species of Salvia genus. Yue 
et al. [48] have reported that S. miltiorrhiza induced a reduction of cytokine expression, thus 
alleviating liver inflammation. In a similar way, Gao et al. [49] have reported the reduction of 
nitric oxide, tumor necrosis factor (TNF-α) and IL-6 secretion in RAW264.7 macrophages by a 
novel compound isolated from S. miltiorrhiza in a LPS inflammatory model. 
4.3 Effect of SSEE on HO-1 expression 
In an inflammatory process, to avoid endothelial dysfunction, there is a tight balance between 
inflammatory and protective molecules. Recent findings indicated that Heme oxygenase-1 (HO-
1), initially studied for its ability to degrade heme, is a key regulator molecule of endothelial 
cell function providing an important cellular defense mechanism against tissue injury [50, 51]. 
Moreover, during chronic inflammation, HO-1 performs a double function inhibiting leukocyte 
infiltration and promoting VEGF-driven non-inflammatory angiogenesis that facilitates tissue 
repair [52]. For this reason, HO-1 gene expression and protein level were evaluated by RT-PCR 
and Western-blot, respectively. Compared to control, SSEE treatment at the highest tested level 
increased HO-1 gene expression (Figure 3a); as concerns protein level, a clearer dose-dependent 
response was observed (Figure 3b). Although LPS itself did induce an increase in HO-1 levels 
[27], upon SSEE treatment the protein level was even higher, and this suggest a possible 
correlation with its antinflammatory properties towards interleukins.  
 
Figure 3. Effects of SSEE on HO-1 expression in LPS-induced pAECs damage. a) Expression of HO-1 




represents the range of relative expression. b) Representative Western Blot of HO-1 and relative 
housekeeping α-tubulin. Data shown are representative of three replicates in at least three independent 
experiments. Each bar represents mean ± S.D. Different letters above the bars indicate significant 
differences (p < 0.05 ANOVA post hoc Tukey’s test). 
4.4 Phytochemical investigation of SSEE 
Phytochemical investigation of the polyphenolic composition was done through both spectrophotometric 
assays and HPLC-DAD (Tab. 2). TPC and TFC suggest that SSEE was rich in polyphenols, and flavonoids 
represented more than 65% of polyphenol structures. TPC through the Folin-Ciocalteau procedure was 
investigated in a wide array of medicinal plants, and values ranging from 9 to 183 mg GAE/g DW in plants 
belonging to different botanical families were reported. Considering the slight differences in the extract 
preparation and the different species investigated by these authors, the TPC content of Salvia sagittata 
extract (10.19 mg GAE/g DW) turned out to be very close to that reported by Kähkönen et al. [53] for 
Thymus vulgaris methanolic extract (9 mg GAE/g DW).  
HPLC-DAD analysis showed that the major phenolic acid-derivative compound in the extract was 
rosmarinic acid (RA), reaching about 50% of TPC. Chlorogenic acid (CHA), cinnamic acid (CA) and 
syringic acid (SA) were also found, although at much lower levels (Tab. 2), together with hesperetin and 
quercetin-3-O-glucoside, which were minor components. These results are in agreement with a recent 
phytochemical screening carried out on three plant extracts belonging to Lamiaceae family by Cocan et al. 
[54], which demonstrates that rosmarinic acid represents the major phenolic acid compound of an ethanolic 
extract from Salvia officinalis (L.) leaves.  
5. Conclusions 
To our knowledge, this is the first phytochemical and study, of the in vitro anti-inflammatory and 
antioxidant activities of the ethanolic extract obtained from leaves of Salvia sagittata. Considering that 
rosmarinic acid, which is known to show anti-inflammatory and anti-angiogenic activities [55, 56], is the 
main compound in SSEE, our data suggest that probably Rosmarinic acid is responsible of the majority of 
the reported protective effects and justify its use in traditional medicine.  
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4.5 Clinopodium tomentosum 
Manuscript in preparation 
1. INTRODUCTION 
Medicinal plants are presently in demand and their acceptance is increasing progressively, 
probably because according the World Health Organization (WHO) approximately 80% of the 
world’s population use them as a primary source of healthcare (Jamshidi-Kia et al. 2017; Fabricant 
& Farnsworth 2001). In Ecuador, considered a megadiverse country for its high number of vegetal 
and animal species, have so far been recorded an estimated of 17.000 plant species of which more 
than 3000 are medicinal plants with promising potential and are widely used in several healing 
cultures (Harling, 1986., Jørgensen et al., 2006, Ulloa Ulloa and Neill., 2005). Nevertheless, in the 
most part of the cases, medicinal plants remain untested and their use also not monitored whereby 
information about dose, route of administration and potential adverse effects are limited and 
identification of the safest and most effective therapies as well as the promotion of their rational 
use it is nonexistent (Naranjo and Escaleras, 1995). 
Lamiaceae family own popular aromatic plants growing in many regions of the world. Most of 
them has been studied for their biological and medical applications (Uritu et al. 2018; Vladimir-
Knezevic et al. 2014). In Ecuador, lamiaceae family present more than 50 medicinal species that 
are used to treat different affections (De La Torre et al., 2008). Clinopodium genus is widely 
distributed in southern and southeastern Europe, Asia and south and north America (Burk et al., 
2009; Estrada-Reyes et al., 2010) whereby many species of the genus are used as medicinal plants. 
Previous phytochemical studies on Clinopodium genus have revealed the presence of several 
compounds including flavonoids (Estrada-Reyes et al., 2010), phenylpropanoids (Zeng et al. 
2016), diterpenes and triterpenoid saponins (Zhu et al. 2017), as well as volatile and fatty oils, 
which exhibit diverse biological activities (Cassani et al., 2013; Chen et al., 2015; Sarikurkcu et 
al., 2015). Ecuador possess 7 types of Clinopodium distributed in the central region used, not only, 
for their medicinal properties. Clinopodium tomentosum (Kunth) Govaerts, commonly known as 
“Pumin”, is a sub-shrub with small orange-yellow colored flowers, that grows between 2000 and 
4000 m a.s.l. In the traditional medicine, local people use the aerial parts of the plant to treat 
respiratory affections, inflammation and gastrointestinal disorders (De La Torre et al., 2008). 
Despite the traditional uses of the plant, at our knowledge, only the phytochemical composition of 





Vascular endothelium is the largest organ in the body that is indispensable for the regulation and 
maintenance of the homeostasis of the whole organism (Hadi et al. 2005). Different kind of cells 
forming vascular tone, among them, endothelial cells (EC) constitute a barrier between the blood 
and the interstitium that control vascular permeability, adhesion molecule expression, platelet 
activation, fibrinolysis, inflammation, angiogenesis, and thromboresistance (Deanfield et al. 2007; 
Roumenina et al. 2016). Since endothelial cells perform multiple functions and the increasing 
number of publications that report the use of primary cultures in biological research, Bernardini et 
al., 2005 have isolated and characterized primary culture of porcine aortic endothelial cells which 
have been used to evaluate the effects of different external agents in the endothelium (Botelho et 
al. 2015; Bernardini et al. 2018; Bertocchi et al. 2018). 
Angiogenesis is the process of forming new vessels from pre-existing vasculature and is tightly 
controlled by a balance of pro-angiogenic and inhibitor factors (Fan et al.,  2006). Different cellular 
types (endothelial cells, fibroblasts, macrophages) and the surrounding extracellular matrix 
interplays a fundamental role in this complex process (Tonnesen et al., 2000). The physiological 
angiogenesis is essential for normal development and wound-healing/reproductive function, 
nevertheless its abnormal regulation has been implicated in the pathogenesis of several diseases 
(Carmeliet et al, 2000, 2003). Insufficient angiogenesis caused by the inadequate production of 
angiogenesis growth factors and/or excessive amounts, and not only, of angiogenesis inhibitors 
could produce different coronary artery diseases (Libby & Theroux 2005). Excessive angiogenesis 
is critical for the initiation, growth, and metastasis of different tumors (Huang & Bao 2004).  
Despite, the traditional use of Clinopodium tomentosum, no studies regarding the biological effects 
in vivo or in vitro have been reported. Thus, the present research was performed with the purpose 
to evaluate the effects of an ethanolic extract of Clinopodium tomentosum on vascular endothelium 
using porcine aortic endothelial cells. Additionally, the phytochemical analysis and its antioxidant 
activity were reported.  
2. MATERIALS AND METHODS 
2.1 Chemicals and reagents  
Human Endothelial Serum Free Medium (hESFM), heat inactivated fetal bovine serum (FBS), 
antibiotic-antimycotic and Dulbecco’s phosphate buffered saline (DPBS) phosphate buffered 
saline (PBS) were purchased from Gibco-Life technologies (Carlsbad CA, USA). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Sigma 




(DPPH), 6-hydroxyl-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox), gallic acid, rutin, 
phenolic acids (4-hydroxybenzoic acid, caffeic acid, chlorogenic acid, ferulic acid, gallic acid, p-
coumaric acid, synapic acid, syringic acid, trans-cinnamic acid, rosmarinic acid, quercetin, 
quercetin-3-O-glucoside, quercetin-3-O-ramnoside, quercetin-3-O-galactoside, kaempferol, 
kaempferol-3-O-rutinoside, hesperetin, hesperidin) pure standards (>99.5% purity) in powder 
form, and HPLC-grade solvents were purchased from Sigma-Aldrich Italia (Milan, Italy). All 
standards were prepared as stock solutions at 1 mg/mL in methanol and stored in the dark at -18 
°C for less than three months. 
2.2 Preparation of plant extract 
Clinopodium tomentosum (Kunth) Govaerts (CT) plants were collected, according to previous 
authorization of Ministry of the Environment (Nro. 003-IC-DPACH-MAE-2018-F), in Riobamba 
Ecuador on May 2016. The plants were identified and certified by Escuela Superior Politecnica de 
Chimborazo Herbarium, Riobamba, Ecuador and a voucher specimen was deposited (N. 702). 
Dried leaves (300 g) were ground and extracted with 96% ethanol for 48 h at room temperature. 
After filtration, the solvent was evaporated using a rotary vacuum evaporator (Büchi Ch-9230 
Flawil, Switzerland) and dried in vacuum at 40 °C to obtain EtOH extract with a yield of 6.18%. 
For experiments, the dry extract was dissolved in ethanol. The stock solution (20 mg/mL) was 
further used for HPLC analysis or diluted in culture media and membrane filtered by a 0.2 µm 
Millipore filter (Millipore, Darmstadt, Germany). 
2.3 Total Phenol content and Total Flavonoid content  
Total Phenol content (TPC) was determined using the Folin–Ciocalteu method (Singleton and 
Rossi, 1965). 50 µL of diluted extract were mixed with 250 µL of a ten-fold-diluted Folin–
Ciocalteu phenol reagent. After 1 min, 800 µL of 30% sodium carbonate solution were added to 
the mixture, shaken thoroughly and diluted to 1.6 ml by adding 500 µL of distilled water. The 
mixture was allowed to stand for 40 min at r.t. and the blue color formed is measured at 700 nm 
using a UV-VIS spectrophotometer (V-630 Jasco, Jasco Europe S.r.l., Cremella, Italy). A 
calibration curve of gallic acid (ranging from 5 to 500 µg/ml) was prepared and the results, 
determined from regression equation of the calibration curve, were expressed as mg Gallic Acid 
Equivalents (GAE) per g. of extract.  
Total Flavonoid content (TFC) was determined according to Zhishen et al. (1999) with some 




with distilled water. 300 µL of 5% NaNO2 were added and the mixture was mixed well. After 5 
min, 3 mL of a 10% AlCl3 solution were added. After 6 min, 2 mL of 1 M NaOH solution were 
added, and the total volume was made up to 10 mL with distilled water. The mixture was mixed 
well again, and the absorbance was measured against a blank at 510 nm with a UV-visible 
spectrophotometer. Rutin was used as the standard for the calibration curve. The flavonoid content 
was calculated using the regression equation based on the calibration curve, and results are 
expressed as mmol Rutin Equivalents (RE) /g. extract. 
2.4 HPLC determination of phenolic acids and flavonoids  
20 µL of ethanolic extract were injected into the HPLC system (Jasco, Tokyo, Japan; PU-4180 
pump, MD-4015 PDA detector, AS-4050 autosampler). The stationary phase was an Agilent 
(Santa Clara, CA, USA) Zorbax Eclipse Plus C18 reversed-phase column (100 mm x 3 mm I.D., 
3.5 µm). The chromatographic method for the analysis of phenolic acids was adapted from Mattila 
and Kumpulainen, (2002). Gradient elution was carried out with a mixture of acidic phosphate 
buffer (50 mM, pH 2.5) and acetonitrile flowing at 0.7 mL/min. The signals at 254, 280 and 329 
nm were used for analyte quantitation. The recovery values of phenolic acids in spiked samples 
ranged from 78.8 to 92.2% (RSD < 9.8%, n = 6). The chromatographic method for the analysis of 
flavonoids was adapted from Wojdyło et al., (2014). Gradient elution was carried out with a 
mixture of 4.5% formic acid and acetonitrile. The runs were monitored at the following 
wavelengths: flavan-3-ols at 280 nm, flavonol glycosides at 360 nm. PDA spectra were measured 
over the wavelength range of 200−600 nm in steps of 2 nm. Retention times and spectra were 
compared with those of pure standards. Calibration curves were constructed for all standards at 
concentrations ranging from 1.0 to 100.0 ppm (r2 ≤ 0.9998). Results are expressed as mg/g extract.  
2.5 Antioxidant activity assays 
Antioxidant activity (AA) of the extract was measured by the ORAC and DPPH assays. The 
ORAC assay was performed in an automated plate reader (Victor 3, Perkin Elmer) with 96-well 
plates, according to Ou et al., (2001) with some modifications. All reagents were freshly prepared 
before the assay. In each well, 210 µl of Fuoresceine (10 nM) and 35 µl of sample, blank (10 mM 
phosphate buffer, pH=7.4), or standard (Trolox in the range 1-50 µM) were placed. The plate was 
heated to 37 °C for 10 min, and then 35 µl of AAPH (240 mM) were added, immediately before 




Measurements were then taken every 1.5 min until the relative fluorescence intensity (FI %) was 
less than 5% of the value of the initial reading. The final ORAC values were calculated by using 
a regression equation between the Trolox concentration and the net area under the FL decay curve 
and were expressed as mmole Trolox equivalents per g. of extract. 
The DPPH assay was done according to the method of Brand-Williams et al., (1995) with some 
modifications. A stock solution was prepared by dissolving 24 mg DPPH with 100 mL methanol 
and then stored at -20°C until needed. The working solution was prepared by mixing 10 mL stock 
solution with 45mL methanol to obtain an Abs of 1.1 ±0.02 units at 515 nm using an UV-VIS 
spectrophotometer. 150 µL of ethanolic extract were allowed to react with 2850 µL of the DPPH 
solution for 24 h in the dark. The absorbance was then taken at 515 nm. Results were determined 
from the regression equation of the calibration curve of Trolox in the range 25-500 µM, and 
expressed as mmol TE/g extract.  
2.6 Cell culture and treatments 
Porcine aortic endothelial cells (pAECs) were isolated and maintained as previously described by 
Bernardini et al., 2005. For the experiments, cells from the third to the tenth passage were used. 
Cells were seeded and routinely cultured in T25 tissue culture flasks (4x105 cells/flask) (T 25-
Falcon, Beckton-Dickinson, Franklin Lakes, NJ, USA). Successive experiments were conducted 
in 96-well plates (cell viability and anti-inflammatory test), 24-well plates (wounding migration 
assay) and 8-slide chambers (tube formation assay) (Beckton-Dickinson) at confluent cultures. 
Cells were cultured in hESFM, added with 5%FBS and 1x antimicrobial/antimycotic solution in a 
5% CO2 atmosphere at 38.5°C.  
The dry extract was dissolved in ethanol (98%) to obtain a stock solution (20 mg/mL) and then in 
culture medium to obtain desired concentrations (1 – 200 µg/mL) for cell exposure. Ethanol (1%) 
was used as control group.  
2.7 Cell viability 
Viability was determined using MTT assay.  Briefly, pAECs were seeded in 96-well culture 
plates at a density of 3 × 103 cells/well and incubated for 24 h. Then, media were replaced with 
hESFM containing 5% FBS and increasing CTEE doses (1, 10, 50, 100 and 200 µg/mL), and 
incubated for another 24 hours at 38.5°C. Next, MTT solution (5 mg/mL in PBS) was added to 
a final concentration of 0.5 mg/mL and then incubated for 2 hours at 38.5°C, followed by the 




using Infinite® F50/Robotic absorbance microplate readers from TECAN Life Sciences 
(Männedorf, Switzerland). 
2.8 In vitro wounding migration assay  
pAECs (approximately 4x104 cells/well) were seeded in 24-well culture plate and incubated at 
38,5°C and 5% CO2 until confluence. Then, cells were scratched with a 200 μL pipette tip along 
the diameter of the well and medium was aspirated and washed twice with PBS, to remove 
detached cell, and incubated in hESFM with 1% FBS (to minimize cells proliferation) and 
increasing doses (1, 10, 25, 50 and 100 µg/mL) of CTEE. These culture conditions minimized 
pAECs proliferation. Wound diameters were photographed at 24 hours. Wound closure was 
determined with optical microscopy at 40× magnification. Images were acquired using a Nikon 
epifluorescence microscope equipped with digital camera (Nikon, Yokohama, Japan) 
2.9 In vitro tube formation assay 
The experiments were carried out using 8 slide chambers (BD Falcon Bedford, MA USA) coated 
with undiluted Geltrex™ LDEV-Free Reduced Growth Factor Basement Membrane Matrix. 
Firstly, extracellular matrix coating was carried out in 8 wells glass slide 1 hour before the 
seeding in a humidified incubator, at 38.5°C, 5% CO2. Then pAECs (8x10
4 cells/well) were 
seeding with increasing doses (1, 10, 25, 50 and 100 µg/mL) of CTEE for 18 h. At the end of 
experimental time, images were acquired using a digital camera installed on a Nikon contrast 
phase microscope (Nikon, Yokohama, Japan) and analyzed by open software Image J 64. 
2.10 Cell viability after LPS injury 
Briefly, pAECs were seeded in 96-well culture plates at a density of 12×103 cells/well and 
incubated for 24 h. Then exposed to different concentrations of CTEE (25, 50 and 100 µg/mL) in 
presence of LPS (25 µg/mL) and incubated for another 24 hours at 38.5°C. Cell viability was 
evaluated by MTT assay. 
3. STATISTICAL ANALYSIS 
Each treatment was replicated three times or eight times (viability and anti-inflammatory test) in 
three independent experiments. The data were analysed by a one-way analysis of variance 
(ANOVA) followed by the post hoc Tuckey comparison Test. Differences of at least p < 0.05 were 
considered significant. Statistical analysis was carried out using GraphPad Prism 7 software. 
4. RESULTS 




The yield of the extract was 5.35% (w/w). As shown in Table 1, the phytochemical analysis of 
CTEE revealed the presence of polyphenol (140.15±0.12 mg GAE/g) and flavonoids 
(97.38±0.62 mg RE/g) as active constituents of the extract. HPLC-DAD analysis showed high 
quantity of phenolic compounds such as rosmarinic acid (37.03±0.58 mg/g), chlorogenic acid 
(1.66±0.35 mg/g) and cynnamic acid (0.653±0.03 mg/g) among others, as well as, flavonoids 
such as hesperidin (16.76±0.89 mg/g), hesperetin (4.14±0.14 mg/g), kaempferol (3.97±0.25 
mg/g) and rutin (1.95±0.06 mg/g). Moreover, CTEE showed high antioxidant activity that was 
measured by DPPH (0.93±0.11 mmol TE/g) and ORAC (4.14±0.24 mmol TE/g) assays.  
Table 1. Antioxidant Activity (AA), TPC, TFC, phenolic acids and flavonoid content in CTEE. 









































4.2 Effect of CTEE on pAECs viability 
pAECs viability, after 24 hours of treatment with CTEE, were not affected at any concentration 





Figure 1. Effect of Clinopodium tomentosum ethanolic extract on pAECs cell viability. Cells were treated 
with different concentrations (1, 10, 25, 50, 100 and 200 µg/mL) of CTEE and cell viability was measured 
by MTT assay. Data shown are representative of 8 independent replicates. Each column represent mean ± 
S.D. Different letters above the bars indicate significant differences (p < 0.05 ANOVA post hoc Tukey’s 
test) 
4.3 Effect of CTEE on pAECs wounding capacity and network formation. 
The migration ability of pAECs in a wounded edge was tested by scratch test. Treatment with 
CTEE markedly increased pAECs migration compared with the control, in fact migration was 
significantly increased by about 59% at the concentration of 50 µg/mL (Figure 2). Then, pAECs 
ability to form a capillary network was tested in a Geltrex-based assay. CTEE at 25 and 50 µg/mL 
showed a significant increase in number of master junction on pAECs compared with the control 
group (Figure 3). 
 




























Figure 2. Effect of Clinopodium tomentosum ethanolic extract on pAEC migration capacity. Migration was 
observed using a phase-contrast microscope, at a 40× magnification, and the closure area, after treatment 
with different concentrations of CTEE compared with control group, was calculated. (a) CTEE at 25 and 
50 µg/mL reduced the scratched damaged. (b) Data shown are representative of at least three independent 
experiments after 24h. Each column represent mean ± S.D. Different letters above the bars indicate 





Figure 3. Effect of Clinopodium tomentosum ethanolic extract on pAECs angiogenesis. pAECs were 
cultured on a extracellular matrix for 18 h with different concentrations (1, 10, 25, 50, 100 µg/mL) of 
plant extract. Photographs were recorded at 6 h and 18 h after treatment. (a) CTEE at 25 and 50 µg/mL 
induce a capillary like network compared with control group. (b). Data shown are representative of at 
least three independent experiments after 18h. Each column represent mean ± S.D. Different letters above 
the bars indicate significant differences (p < 0.02 ANOVA post hoc Tukey’s test) 
4.4 Effect of CTEE on LPS-induced cell death  
LPS produce an evident cytotoxicity on pAECs, reducing nearly the 25% of their viability. 
Treatment with CTEE significantly reduced the cytotoxicity induced by LPS restoring to 
physiological levels at all the concentrations tested (Figure 4). 
 
Figure 4. Effect of Clinopodium tomentosum ethanolic extract on LPS-induced pAECs damage. Cell 
viability were measured by MTT assay after treatement with LPS (25 µg/mLa) and different concentrations 
of CTEE (25, 50, 100 µg/mL). Data shown are representative of 8 independent replicates. Each column 
represent mean ± S.D. Different letters above the bars indicate significant differences (p < 0.05 ANOVA 
post hoc Tukey’s test) 
5. DISCUSSION 
Despite the commonly use of medicinal plants in Ecuador, there is a lack of scientific 
information that support their uses. Especially in the case of Clinopodium tomentosum, in spite 
of being an endemic plant, few studies have been reported so far. Therefore, our study evaluated 
the phytochemical composition, antioxidant capacity as well as the biological effects of CTEE 
on pAECs physiology. 
Previously studies have demonstrated that in vitro primary culture of porcine aortic endothelial 
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and anti-inflammatory activities. (Botelho et al. 2015; Bernardini et al. 2018; Bertocchi et al. 
2018). 
Ideally to ensure the safety of any natural product or medicinal plants a vitality test on cells 
should be done. We demonstrated that treatment with CTEE, not only, not influence on pAECs 
viability but also induce cell proliferation (Fig. 1). In the same line, Burk et al. 2009 reported a 
similar trend when tested the effects of Clinopodium vulgare L in cell viability of RAW264.7 
macrophages. Additionally, other authors have confirmed the protective effects in vivo and in 
vitro of different Clinopodium species (Dzhambazov et al., 2002; Estrada-Reyes et al., 2010; 
Mohanty et al., 2017).  
Endothelial cells perform a pivotal role in the maintenance of the vascular integrity preventing 
many pathological alterations, including cardiovascular diseases (CDVs) (Roumenina et al. 2016). 
In addition, endothelial cells migration ability is critical in the physiological and pathological 
angiogenesis. 
Hence the effects of CTEE on pAECs angiogenesis were tested. In our research pAECs migration 
and tube formation were improved after 24 hours of treatment (Fig. 2). No date regarding the 
angiogenic activity of CTEE in endothelial cells has been reported until now. Nevertheless, Zeng 
et al. 2016 has shown that phenolic compounds of Clinopodium chinensis exerted a strong 
protective effect in vascular endothelial cells injury. Moreover, Chen et al. 2015 have demostrated 
in vivo and in vitro that total flavonoids from Clinopodium chinensis protect against doxorubicin-
induced cardiotoxicity by suppressing the phosphorylation of JNK, p38, ERK and overexpression 
of p53. Likewise, Zhang et al. 2018 following the previosly research has demostrated that 
pretreatment of total flavonoids from Clinopodium chinensis protect against ischemic myocardial 
injury in vivo and in vitro by the phosphorylation of AKT via the activation of the Nrf2/HO-1 
signaling pathway. 
Since CTEE has been used as anti-inflammatory agent in the traditional medicine, we decided to 
analyze also its effects against LPS-induce inflammation on pAECs by an MTT assay. After 24 
hours of treatment, the inflammatory damage produced by LPS was reduced reaching its maximum 
effect at 100 µg/mL (Fig. 3). Similar results were reported by Burk et al. 2009, in which the 
aqueous extract of Clinopodium vulgare reduced the LPS-inflammatory effect on 264.7 murine 
macrophages by suppressing the activation of NF-kB pathway. 
Based in the phytochemical composition and the major compounds reported in CTEE, is not 




studies confirm the protective and anti-inflammatory effect of rosmaric acid (Cao et al. 2016; Han 
et al. 2017; Rocha et al. 2015) as well as the protective role of hespedirin in cardiovascular diseases 
and its angiogenic effects in diabetic foot ulcer (Roohbakhsh et al. 2015; Wang et al. 2018; Li et 
al. 2018).  
The present study is the first to provide scientific information that support the use Clinopodium 
tomentosum in ecuadorian traditional medicine and our experiments demonstrated the angiogenic 
and anti-inflammatory effects of CTEE on pAECs, probably the biological properties could be due 
to its phytochemical compositon and the antioxidant activity. Nevertheless, further research should 
be performed to elucidate the possible the pathway by which exert its effects.  
6. Conclusion 
To our knowledge, this is the first phytochemical and in vitro study the angiogenic, anti-
inflammatory and antioxidant activities of the ethanolic extract obtained from leaves of 
Clinopodium tomentosum.  
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This thesis work reported the results of the phytochemical and biological studies of Cucumis sativus L, 
Boswellia serrata Roxb. ex Colebr, Salvia sagittata Ruiz & Pav C and Clinopodium tomentosum (Kunth) 
Harley. These medicinal plants have demonstrated their anti-inflammatory activity in vitro on primary 
cultures of porcine aortic endothelial cells.  
In the case of the endemic Ecuadorian medicinal plants, it is the first report of the phytochemical 
characterization and, on the other ands, of the evidence-based demonstration of at least one of their 
traditional uses.  
Moreover the studies confirm primary culture of porcine endothelial cells as an interesting screening model 





6 Bibliografy (not included in specific 
chapters) 
Acosta-Solís, M. 1992b. Vademécum de plantas medicinales del Ecuador. FESO; Abya-Yala, Quito. 
Ahmad, K., Ahmad, M. & Weckerle, C., 2015. Ethnoveterinary medicinal plant knowledge and practice 
among the tribal communities of Thakht-e-Sulaiman hills, west Pakistan. Journal of 
ethnopharmacology, 170, pp.275–83. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26002769. 
Aird, W., 2006. The Endothelium: A Comprehensive Reference, Taylor & Francis Group. Available at: 
https://books.google.com.ec/books?id=RTkZPQAACAAJ. 
Aird, W.C., 2008. Endothelium in health and disease. Pharmacological reports : PR, 60(1), pp.139–43. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18276995. 
Akerreta, S., Calvo, M.I. & Cavero, R.Y., 2010. Ethnoveterinary knowledge in Navarra (Iberian Peninsula). 
Journal of Ethnopharmacology, 130(2), pp.369–378. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20573568 [Accessed October 29, 2018]. 
Angelo, D. & J.M. Capriles. 2004. La importancia de las plantas psicotrópicas para la economía de 
intercambio y relaciones de interacción en el altiplano sur andino. Chungará 36: 1023–1035. 
Antonio, R. et al., 2015. Investigation of urban ethnoveterinary in three veterinary clinics at east zone of 
São Paulo city, Brazil. Journal of Ethnopharmacology, 173, pp.183–190. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/2620564. 
Bach, F.H., 1994. The endothelial cell: an obstacle to xenografting. Pathologie-biologie, 42(3), pp.213–6. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/8090568. 
Benítez, G., González-Tejero, M.R. & Molero-Mesa, J., 2012. Knowledge of ethnoveterinary medicine in 
the Province of Granada, Andalusia, Spain. Journal of Ethnopharmacology, 139(2), pp.429–439. 
Bennett, B.C. & Prance, G.T., 2000. Introduced Plants in the Indigenous Pharmacopoeia of Northern South 
America INTRODUCED PLANTS IN THE INDIGENOUS PHARMACOPOEIA OF NORTHERN 
SOUTH AMERICA. Economic Botany, 54(1994), pp.90–102. 
Betz, C. et al., 2016. Cell behaviors and dynamics during angiogenesis. Development, 143(13), pp.2249–
2260. Available at: http://www.ncbi.nlm.nih.gov/pubmed/27381223. 
Birch, K.A. et al., 1992. Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact 
and minimally permeabilized human umbilical vein endothelial cells. The Journal of cell biology, 




Birch, K.A. et al., 1994. Prolonged peak elevations in cytoplasmic free calcium ions, derived from 
intracellular stores, correlate with the extent of thrombin-stimulated exocytosis in single human 
umbilical vein endothelial cells. Journal of Cellular Physiology, 160(3), pp.545–554. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7521337. 
Buitrón, X. 1999. Ecuador: uso y comercio de plantas medicinales, situación actual y aspectos importantes 
para su conservación. Traffic International, Quito. 
Burri, P.H., Hlushchuk, R. & Djonov, V., 2004. Intussusceptive angiogenesis: Its emergence, its 
characteristics, and its significance. Developmental Dynamics, 231(3), pp.474–488. Available at: 
http://doi.wiley.com/10.1002/dvdy.20184. 
Byga, A. & Balslevb, H., 2004. FACTORS AFFECTING LOCAL KNOWLEDGE OF PALMS IN 
NANGARITZA VALLE~ SOUTHEASTERN ECUADOR Journal of EthnO[iioliDgy 24(2): 255-278 
Fall/Winter 2004, Available at: https://ethnobiology.org/sites/default/files/pdfs/JoE/24-
2/BygBalslev2004.pdf. 
Cerón, C.E. & D. Gaybor. 1994. Plantas medicinales de los mercados de Guaranda. En: Memorias de las 
XVIII Jornadas Ecuatorianas de Biología. SEB; Universidad Técnica de Ambato, Ambato. 
Cerón, C.E., C. Montalvo, J. Umenda & E. Umenda. 1994a. Etnobotánica y notas sobre la diversidad 
vegetal en la comunidad Cofán de Sinangüé, Sucumbíos, Ecuador, Vol. 2. Editcar, Quito. 
Clark, P.R. et al., 2007. Increased ICAM-1 Expression Causes Endothelial Cell Leakiness, Cytoskeletal 
Reorganization and Junctional Alterations. Journal of Investigative Dermatology, 127(4), pp.762–
774. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17195014. 
Cragg, G.M. & Newman, D.J., 2001. Natural Product Drug Discovery in the Next Millennium. 
Pharmaceutical Biology, 39(sup1), pp.8–17. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21554167. 
Cragg, G.M., Newman, D.J. & Snader, K.M., 1997. Natural Products in Drug Discovery and Development. 
Journal of Natural Products, 60(1), pp.52–60. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9014353. 
D, V. der M., Swan, G.E. & Botha, C.J., 2001. Journal of the South African Veterinary Association., [South 
African Veterinary Association.]. Available at: 
https://jsava.co.za/index.php/jsava/article/view/651/625. 
Dothel, G. et al., 2013. Animal models of chemically induced intestinal inflammation: Predictivity and 





Egan, K. & FitzGerald, G.A., 2006. Eicosanoids and the vascular endothelium. Handbook of experimental 
pharmacology, (176 Pt 1), pp.189–211. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16999220. 
Estrella, E. 1995. Plantas medicinales Amazónicas: realidad y perspectivas. Tratado de Cooperación 
Amazónica, Lima. 
Feng, D. et al., 1998. Neutrophils emigrate from venules by a transendothelial cell pathway in response to 
FMLP. The Journal of experimental medicine, 187(6), pp.903–15. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9500793. 
Frangogiannis, N.G., 2006. Targeting the inflammatory response in healing myocardial infarcts. Current 
medicinal chemistry, 13(16), pp.1877–93. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16842199. 
Gentry, A.H. 1990. Floristic similarities and differences between southern Central America and upper and 
central Amazonia. 141–157. In: A.H. Gentry (ed.), Four neotropical rainforests. Yale University 
Press, New Haven. 
Goepfert, C. et al., 2000. CD39 modulates endothelial cell activation and apoptosis. Molecular medicine 
(Cambridge, Mass.), 6(7), pp.591–603. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/10997340. 
Guerrero, F. 2005. Población indígena y afroecuatoriana en Ecuador: Diagnóstico sociodemográfico a partir 
del censo de 2001. Comisión Económica para América Latina y el Caribe (CEPAL), Santiago de 
Chile. 
Heltianu, C., Simionescu, M. & Simionescu, N., 1982. Histamine receptors of the microvascular 
endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding 
sites in venules. The Journal of cell biology, 93(2), pp.357–64. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7201474. 
Hooijmans, C.R. & Ritskes-Hoitinga, M., 2013. Progress in Using Systematic Reviews of Animal Studies 
to Improve Translational Research. PLoS Medicine, 10(7), p.e1001482. Available at: 
https://dx.plos.org/10.1371/journal.pmed.1001482. 
Hunt, B.J. & Jurd, K.M., 1998. Endothelial cell activation. A central pathophysiological process. BMJ 





Jørgensen, P.M. & S. León-Yánez (eds.). 1999. Catalogue of the vascular plants of Ecuador. Missouri 
Botanical Garden Press, St. Louis. 
Judd, W.S., Campbell, C.S. & Kellogg, E.A., 2002. Plant systematics : a phylogenetic approach, 
Kennedy, D.O. & Wightman, E.L., 2011. Herbal extracts and phytochemicals: plant secondary metabolites 
and the enhancement of human brain function. Advances in nutrition (Bethesda, Md.), 2(1), pp.32–
50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22211188. 
Keramaris, N.C. et al., 2008. Translational research: From benchside to bedside. Injury, 39(6), pp.643–650. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18508055. 
Kilkenny, C. et al., 2010. Improving bioscience research reporting: The ARRIVE guidelines for reporting 
animal research. Journal of Pharmacology and Pharmacotherapeutics, 1(2), p.94. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21350617. 
Kilkenny, C. et al., 2009. Survey of the Quality of Experimental Design, Statistical Analysis and Reporting 
of Research Using Animals M. McLeod, ed. PLoS ONE, 4(11), p.e7824. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/19956596. 
Klein, D. et al., 2014. Nestin(+) Tissue-Resident Multipotent Stem Cells Contribute to Tumor Progression 
by Differentiating into Pericytes and Smooth Muscle Cells Resulting in Blood Vessel Remodeling. 
Frontiers in Oncology, 4, p.169. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25019063. 
Kliebenstein, D.J., 2013. Making new molecules — evolution of structures for novel metabolites in plants. 
Current Opinion in Plant Biology, 16(1), pp.112–117. Available at: 
https://www.sciencedirect.com/science/article/pii/S1369526612001744?via%3Dihub. 
Kohn, E.O. 1992b. La cultura médica de los runas de la región amazónica ecuatoriana. Colección Hombre 
y Ambiente No. 21. Abya-Yala, Quito. 
Korshunov, V.A., Schwartz, S.M. & Berk, B.C., 2007. Vascular Remodeling. Arteriosclerosis, Thrombosis, 
and Vascular Biology, 27(8), pp.1722–1728. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17541029. 
Kothari, B. 1993. Ñucanchic panpa janpicuna/Plantas medicinales del campo. Abya-Yala, Quito. 
Lans, C. et al., 2009. Medicinal plants used in British Columbia, Canada for reproductive health in pets. 
Preventive Veterinary Medicine, 90(3–4), pp.268–273. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/19482367. 
Ley, K. & Reutershan, J., 2006. Leucocyte-endothelial interactions in health and disease. Handbook of 





Lorant, D.E. et al., 1991. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or 
thrombin: a juxtacrine system for adhesion and activation of neutrophils. The Journal of cell biology, 
115(1), pp.223–34. Available at: http://www.ncbi.nlm.nih.gov/pubmed/1717478. 
Lückhoff, A. & Clapham, D.E., 1992. Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca2+-
permeable channel. Nature, 355(6358), pp.356–358. Available at: 
http://www.nature.com/articles/355356a0. 
Marchesi, V.T., 1961. The site of leucocyte emigration during inflammation. Quarterly journal of 
experimental physiology and cognate medical sciences, 46, pp.115–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/13766496. 
Martin, M., Mathias, E. & McCorkle, C.M., 2001. Ethnoveterinary medicine: an annotated bibliography of 
community animal healthcare. Ethnoveterinary medicine: an annotated bibliography of community 
animal healthcare. Available at: https://www.cabdirect.org/cabdirect/abstract/20013095127. 
Martin, M.U. & Wesche, H., 2002. Summary and comparison of the signaling mechanisms of the 
Toll/interleukin-1 receptor family. Biochimica et biophysica acta, 1592(3), pp.265–80. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12421671. 
McCorkle, C.M., 1995. Back to the future: Lessons from ethnoveterinary RD&amp;E for studying and 
applying local knowledge. Agriculture and Human Values, 12(2), pp.52–80. Available at: 
http://link.springer.com/10.1007/BF02217297. 
McGonigle, P. & Ruggeri, B., 2014. Animal models of human disease: Challenges in enabling translation. 
Biochemical Pharmacology, 87(1), pp.162–171. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23954708. 
Mentzer, S.J. & Konerding, M.A., 2014. Intussusceptive angiogenesis: expansion and remodeling of 
microvascular networks. Angiogenesis, 17(3), pp.499–509. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/24668225. 
Mulvany, M., 1999. Vascular remodelling of resistance vessels: can we define this? Cardiovascular 
Research, 41(1), pp.9–13. Available at: https://academic.oup.com/cardiovascres/article-
lookup/doi/10.1016/S0008-6363(98)00289-2. 
Niu, J. et al., 2003. G Protein βγ Subunits Stimulate p114RhoGEF, a Guanine Nucleotide Exchange Factor 





Ortega, F. 1988. Hierbas medicinales de Quito urbano. Ministerio de Salud Pública; Instituto Nacional de 
Investigaciones Nutricionales y Médico Sociales, Quito. 
Petrache, I. et al., 2003. The Role of the Microtubules in Tumor Necrosis Factor-α–Induced Endothelial 
Cell Permeability. American Journal of Respiratory Cell and Molecular Biology, 28(5), pp.574–581. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/1270701. 
Pober, J.S. et al., 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: 
comparison with tumor necrosis factor and interleukin 1 species. Journal of immunology (Baltimore, 
Md. : 1950), 138(10), pp.3319–24. Available at: http://www.ncbi.nlm.nih.gov/pubmed/3494766. 
Pober, J.S., 1988. Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular 
endothelium. Physiology and pathology. The American journal of pathology, 133(3), pp.426–33. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/2462353. 
Pober, J.S. & Cotran, R.S., 1990. The role of endothelial cells in inflammation. Transplantation, 50(4), 
pp.537–44. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2219269. 
Pober, J.S. & Sessa, W.C., 2007. Evolving functions of endothelial cells in inflammation. Nature Reviews 
Immunology, 7(10), pp.803–815. 
Prescott, S.M., Zimmerman, G.A. & McIntyre, T.M., 1984. Human endothelial cells in culture produce 
platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with 
thrombin. Proceedings of the National Academy of Sciences of the United States of America, 81(11), 
pp.3534–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/6587368. 
Ramakrishna, A. & Ravishankar, G.A., 2011. Influence of abiotic stress signals on secondary metabolites 
in plants. Plant Signaling and Behavior, 6(11), pp.1720–1731. 
Renna, N.F., de las Heras, N. & Miatello, R.M., 2013. Pathophysiology of Vascular Remodeling in 
Hypertension. International Journal of Hypertension, 2013, pp.1–7. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23970958. 
Rodríguez, G. 1995. La faz oculta de la medicina Andina. Colección Amaru. Abya-Yala, Quito. 
Roumenina, L.T. et al., 2016. Endothelial cells: source, barrier, and target of defensive mediators. 
Immunological Reviews, 274(1), pp.307–329. 
Sandercock, P. & Roberts, I., 2002. Systematic reviews of animal experiments. The Lancet, 360(9333), 
p.586. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12241927. 
Sarker, S.D., Latif, Z. & Gray, A.I., 2006. Natural Product Isolation. In Natural Products Isolation. Totowa, 




Schenkel, A.R. et al., 2002. CD99 plays a major role in the migration of monocytes through endothelial 
junctions. Nature Immunology, 3(2), pp.143–150. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11812991. 
Schillhorn van Veen, T.W., 1997. Sense or nonsense? Traditional methods of animal parasitic disease 
control. Veterinary Parasitology, 71(2–3), pp.177–194. Available at: 
https://www.sciencedirect.com/science/article/pii/S0304401797000319. 
Schultes, R.E. & R. Hofmann. 2000. Plantas de los dioses. Fondo de Cultura Económica, México D.F. 
Severino L, Russo R, Autore G, Marzocco S, De Tommasi N. (2008) Use of phytotherapics in dogs and 
cats. Pharmacologyonline, 2, 12-21. 
Teixeira, M.M., Williams, T.J. & Hellewell, P.G., 1993. Role of prostaglandins and nitric oxide in acute 
inflammatory reactions in guinea-pig skin. British journal of pharmacology, 110(4), pp.1515–21. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/8306095. 
Triggle, C.R. et al., 2012. The endothelium: influencing vascular smooth muscle in many ways. Canadian 
Journal of Physiology and Pharmacology, 90(6), pp.713–738. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22625870. 
Ulloa Ulloa, C. & D. Neill. 2005. Cinco años de adiciones a la flora del Ecuador 1999-2004. Editorial 
UTPL, Loja. 
Ulloa Ulloa, C. & P.M. Jørgensen. 1995. Árboles y arbustos de los Andes del Ecuador. Abya-Yala, Quito. 
Ungvari, Z. et al., 2018. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. 
Nature Reviews Cardiology, 15(9), pp.555–565. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/29795441. 
Valencia, R., N. Pitman, S. León-Yánez & P.M. Jørgensen (eds.). 2000. Libro rojo de las plantas endémicas 
del Ecuador 2000. Herbario QCA, Pontificia Universidad Católica del Ecuador, Quito. 
Varea, M.T. 1922. Botánica Médica Nacional. Tip. Vicente León, Latacunga. 
Wanzala W, Zessin K H, Kyule N M, Baumann M P O, Mathias E and Hassanali A 2005: Ethnoveterinary 
medicine: a critical review of its evolution, perception, understanding and the way forward. Livestock 
Research for Rural Development. Volume 17, Article #119. 
http://www.lrrd.org/lrrd17/11/wanz17119.htm 
Willms-Kretschmer, K., Flax, M.H. & Cotran, R.S., 1967. The fine structure of the vascular response in 
hapten-specific delayed hypersensitivity and contact dermatitis. Laboratory investigation; a journal 





Yoo, S.Y. & Kwon, S.M., 2013. Angiogenesis and its therapeutic opportunities. Mediators of inflammation, 
2013, p.127170. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23983401. 
Zavoico, G.B. et al., 1989. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in 
cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or 
platelet-activating factor biosynthesis. Journal of immunology (Baltimore, Md. : 1950), 142(11), 
pp.3993–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2497185. 
Zhang, J. et al., 2010. Biomarkers of Endothelial Cell Activation Serve as Potential Surrogate Markers for 
Drug-induced Vascular Injury. Toxicologic Pathology, 38(6), pp.856–871. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20716788. 
Zhang, R.-Y. et al., 2013. The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both? 
Critical Care, 17(4), p.R178. Available at: 
http://ccforum.biomedcentral.com/articles/10.1186/cc12857. 
 
 
